Saturday, October 31, 2015

EMBASE Cardiac Update AutoAlert: EPICORE Cardiac Surgery Blogger2

Total documents retrieved: 26

Results Generated From:
Embase <1980 to 2015 Week 44>
Embase (updates since 2015-10-22)
Embase <1980 to 2015 Week 44>
Embase (updates since 2015-10-22)


<1>
Accession Number
2015455817
Authors
Wang Z.J. Zhou Y.J. Galper B.Z. Gao F. Yeh R.W. Mauri L.
Institution
(Wang, Zhou, Gao) Beijing Institute of Heart Lung and Blood Vessel
Disease, Beijing Anzhen Hospital, Capital Medical University, Anzhen
Avenue #2, Chaoyang district, Beijing 100029, China
(Wang, Galper, Mauri) Brigham and Women's Hospital, Boston, MA, United
States
(Wang, Galper, Yeh, Mauri) Harvard Medical School, Boston, MA, United
States
(Yeh) Massachusetts General Hospital, Boston, MA, United States
(Yeh, Mauri) Harvard Clinical Research Institute, Boston, MA, United
States
Title
Association of body mass index with mortality and cardiovascular events
for patients with coronary artery disease: A systematic review and
meta-analysis.
Source
Heart. 101 (20) (pp 1631-1638), 2015. Date of Publication: 01 Oct 2015.
Publisher
BMJ Publishing Group
Abstract
Objectives: The association between obesity and prognosis in patients with
coronary artery disease (CAD) remains uncertain. We undertook a
meta-analysis for the effects of body mass index (BMI) on mortality and
cardiovascular events in these patients. Methods: We identified studies
that provided risk estimates for mortality or cardiovascular events on the
basis of BMI in patients with CAD. Summary estimates of relative risks
were obtained for five BMI groups: underweight, normal-weight, overweight,
obese and grade II/III obese. Mortality was analysed separately as
short-term (<6 months) and long-term (>6 months). Results: Data from 89
studies with 1 300 794 patients were included. Mean follow-up of long-term
estimates was 3.2 years. Using normal-weight as the reference, underweight
was associated with higher risk of short-term mortality (2.24 (1.85 to
2.72)) and long-term mortality (1.70 (1.56 to 1.86)), overweight and
obesity were both associated with lower risk of short-term mortality (0.69
(0.64 to 0.75); 0.68 (0.61 to 0.75)) and long-term mortality (0.78 (0.74
to 0.82); 0.79 (0.73 to 0.85)), but the long-term benefit of obesity
disappeared after 5 years of follow-up (0.99 (0.91 to 1.08)). Grade II/III
obesity was associated with lower risk of mortality in the short term
(0.76 (0.62 to 0.91)) but higher risk after 5 years of follow-up (1.25
(1.14 to 1.38)). The similar J-shaped pattern was also seen for
cardiovascular mortality and across different treatment strategies.
Meta-regression found an attenuation of the inverse association between
BMI and risk of mortality over longer follow-up. Conclusions Our data
support a J-shaped relationship between mortality and BMI in patients with
CAD. The limitation of current literature warrants better design of future
studies.

<2>
Accession Number
2015436088
Authors
Marazia S. Urso L. Contini M. Pano M. Zaccaria S. Lenti V. Sarullo F.M. Di
Mauro M.
Institution
(Marazia, Lenti) Cardiology Department, S. G. Moscati Hospital, Taranto,
Italy
(Urso) Department of Cardiology, Prof Petrucciani Rehabilitation Clinic,
Lecce, Italy
(Contini) Cardiovascular Surgery, Villa Verde Clinic, Taranto, Italy
(Pano, Zaccaria) Cardiovascular Surgery, V. Fazzi Hospital, Lecce, Italy
(Sarullo) Cardiovascular Rehabilitation Unit, Buccheri la
FerlaFatebenefratelli Hospital, Palermo, Italy
(Di Mauro) Department of Cardiovascular Disease, University of l'Aquila,
L'Aquila, Italy
Title
The role of ivabradine in cardiac rehabilitation in patients with recent
coronary artery bypass graft.
Source
Journal of Cardiovascular Pharmacology and Therapeutics. 20 (6) (pp
547-553), 2015. Date of Publication: 01 Nov 2015.
Publisher
SAGE Publications Ltd
Abstract
Background: Little is known about ivabradine in cardiac rehabilitation in
patients with coronary artery bypass graft (CABG). Methods: In this
prospective, randomized study, suitable patients admitted for cardiac
rehabilitation after recent CABG were randomized to ivabradine 5 mg twice
a day + standard medical therapy including bisoprolol 1.25 mg once daily
(group I-BB, n = 38) or standard medical therapy including bisoprolol 2.5
to 3.75 mg once daily (group BB, n = 43). Patients were evaluated at
admission, discharge, and 3 months. The primary end point was improvement
in functional status, and other end points were improvement in diastolic
function and recovery of systolic function. End points were assessed by
distance covered in 6-minute walking test (6MWT), percentage with normal
diastolic function, and percentage increase in left ventricular ejection
fraction (LVEF). Results: Cardiac rehabilitation improved functional
capacity in both groups. In group BB, distances covered in the 6MWT at
admission, discharge, and 3 months were 215 +/- 53, 314 +/- 32, and 347
+/- 42 m, respectively. Corresponding distances in group I-BB were 180 +/-
91, 311 +/- 58, and 370 +/- 55 m. Normal diastolic function was restored
in I-BB patients, increasing from 24% at admission to 50% and 79% at
discharge and 3 months; in BB patients, it decreased from 23% to 19% and
16%. The LVEF improved in I-BB patients, from 57% +/- 3% at admission to
62% +/- 4% at discharge and 66% +/- 3% at 3 months, while remaining
unchanged in BB patients (57% +/- 3%, 59% +/- 4%, and 59% +/- 3%).
Conclusion: Adding ivabradine to low-dose bisoprolol during cardiac
rehabilitation in patients with CABG improved functional capacity,
enhanced recovery of systolic function, and reduced diastolic dysfunction.

<3>
Accession Number
2015435235
Authors
Kamalipour H. Shahbazi S. Derakhshan M.M. Moinvaziri M.T. Allahyari E.
Institution
(Kamalipour) Anesthesia Department, Ordibehesht Hospital, Shiraz, Iran,
Islamic Republic of
(Shahbazi, Derakhshan, Moinvaziri, Allahyari) Shiraz Anesthesiology and
Critical Care Research Center, Shiraz University of Medical Sciences,
Shiraz, Iran, Islamic Republic of
Title
Comparison of US-guided catheterization of the right internal jugular vein
using medial-oblique and short axis techniques.
Source
International Cardiovascular Research Journal. 9 (4) (pp 210-215), 2015.
Date of Publication: 2015.
Publisher
Iranian Cardiovascular Research Journal
Abstract
Background: Although some investigations have shown higher rates of
successful first attempt and fewer attempts by using ultrasound-guided
Internal Jugular Vein (IJV) catheterization, arterial puncture is still
common. Objectives: The present study aimed to investigate US-guided
catheterization of the right IJV via medial-oblique technique and also
compare this technique to short-axis technique in open-heart surgery
patients. Patients and Methods: In this randomized clinical trial, 80
patients referred to cardiac operating room of Namazi hospital, Shiraz,
Iran from March to July 2014 were selected using census method. Block
randomization with website was also done. Then, the patients were divided
into two groups of 40, Short Axis Group (SAG) and Medial-Oblique Group
(M-OG). For short-axis technique, patient's head was positioned at zero
degree angulation with his trunk. For medial-oblique technique, on the
other hand, patient's head was tilted to left to 45 degrees between the
head and trunk. Sex, age, Body Mass Index (BMI), access time, guidewire
time, cannulation time, total attempts for catheterization, first, second,
and third attempt success, arterial puncture, hematoma, bleeding, and
catheter malposition were recorded. The overlap between the carotid artery
and IJV in zero- and 45-degree angulation was estimated through ultrasound
print. After all, Kolmogorov-Smirnov test was used to assess normal
distribution of the data. Then, the data were analyzed through Student's
t-test, Mann-Whitney U test, and chi-square test. P < 0.05 was considered
as statistically significant. Results: The results showed no significant
differences between the two groups regarding the duration of different
catheterization steps (P = 0.376). In all the cases in both groups,
accessing the vein was successful with three attempts or less. There were
no clinical complications of catheterization in the two groups. The mean
of overlap was 23.60 +/- 33.47 in zero-degree angulation between the head
and trunk and 32.72 +/- 36.38 in 45-degree angulation and this difference
was statistically significant (P = 0.001). Conclusions: The results of the
present study showed that both US-guided techniques under investigation
had the same duration in different catheterization steps, total success
rate, and primary mechanical complications, and could be used in clinics.

<4>
Accession Number
2015443819
Authors
Priye S. Jagannath S. Singh D. Shivaprakash S. Reddy D.P.
Institution
(Priye, Jagannath, Singh, Shivaprakash, Reddy) Department of Cardiac
Anaesthesiology, Vydehi Institute of Medical Sciences, Bengaluru,
Karnataka 560 066, India
Title
Dexmedetomidine as an adjunct in postoperative analgesia following cardiac
surgery: A randomized, double-blind study.
Source
Saudi Journal of Anaesthesia. 9 (4) (pp 353-358), 2015. Date of
Publication: 01 Oct 2015.
Publisher
Medknow Publications (B9, Kanara Business Centre, off Link Road, Ghatkopar
(E), Mumbai 400 075, India)
Abstract
Objectives: The purpose of this study was to determine analgesic efficacy
of dexmedetomidine used as a continuous infusion without loading dose in
postcardiac surgery patients. Settings and Design: A prospective,
randomized, double-blind clinical study in a single tertiary care hospital
on patients posted for elective cardiac surgery under cardiopulmonary
bypass. Interventions: Sixty-four patients who underwent elective cardiac
surgery under general anesthesia were shifted to intensive care unit (ICU)
and randomly divided into two groups. Group A (n = 32) received a 12 h
infusion of normal saline and group B (n = 32) received a 12 h infusion of
dexmedetomidine 0.4 mug/kg/h. Postoperative pain was managed with bolus
intravenous fentanyl. Total fentanyl consumption, hemodynamic monitoring,
Visual Analogue Scale (VAS) pain ratings, Ramsay Sedation Scale were
charted every 6 <sup>th</sup> hourly for 24 h postoperatively and
followed-up till recovery from ICU. Student's t-test, Chi-square/Fisher's
exact test has been used to find the significance of study parameters
between the groups. Results: Dexmedetomidine treated patients had
significantly less VAS score at each level (P < 0.001). Total fentanyl
consumption in dexmedetomidine group was 128.13 +/- 35.78 mug versus
201.56 +/- 36.99 mug in saline group (P < 0.001). A statistically
significant but clinically unimportant sedation was noted at 6 and 12 h (P
< 0.001, and P = 0.046 respectively). Incidence of delirium was less in
dexmedetomidine group (P = 0.086+). Hemodynamic parameters were
statistically insignificant. Conclusions: Dexmedetomidine infusion even
without loading dose provides safe, effective adjunct analgesia, reduces
narcotic consumption, and showed a reduced trend of delirium incidence
without undesirable hemodynamic effects in the cardiac surgery patients.

<5>
[Use Link to view the full text]
Accession Number
2015455923
Authors
Une D. Al-Atassi T. Kulik A. Voisine P. Le May M. Ruel M.
Institution
(Une, Al-Atassi, Ruel) Division of Cardiac Surgery, University of Ottawa
Heart Institute, 40 Ruskin St., Ottawa, ON, Canada
(Le May) Division of Cardiology, University of Ottawa Heart Institute,
Ottawa, ON, Canada
(Kulik) Lynn Heart and Vascular Institute, Boca Raton, FL, United States
(Voisine) Division of Cardiac Surgery, Hopital Laval, Quebec City, QC,
Canada
(Ruel) Department of Epidemiology and Community Medicine, University of
Ottawa, Ottawa, ON, Canada
Title
Impact of Clopidogrel plus aspirin versus aspirin alone on the progression
of native coronary artery disease after bypass surgery analysis from the
Clopidogrel after surgery for coronary artery DiseasE (CASCADE) randomized
trial.
Source
Circulation. 130 (11) (pp S12-S18), 2014. Date of Publication: 09 Sep
2014.
Publisher
Lippincott Williams and Wilkins
Abstract
Background-The effects of dual antiplatelet therapy with aspirin and
clopidogrel on the progression of native coronary artery disease after
coronary artery bypass grafting are unknown. Methods and Results-In the
Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) trial, a
total of 113 patients were randomized to receive aspirin plus clopidogrel
or aspirin plus placebo for 1 year after coronary artery bypass grafting.
In this secondary analysis, the 92 patients who underwent preoperative and
1-year postoperative angiograms at 2 centers had each of their coronary
stenoses graded serially by using 6 thresholds (grade 0 [0%-24%], grade 1
[25%-37%], grade 2 [38%-62%], grade 3 [63%-82%], grade 4 [83%-98%], and
grade 5 [99%-100%]). We compared the incidence and degree of evolving
coronary artery disease between the 2 treatment groups. A total of 543
preoperative stenoses and occlusions were quantified and followed. At
1-year postoperatively, there were 103 evolving (94 worsened, 9 improved)
and 22 new lesions. The right coronary artery territory and sites proximal
to a graft were more commonly associated with worsening coronary artery
disease (P<0.02). There were no differences in clinical events between
treatment groups, and the proportion of patients with evolving or new
lesions was also similar (70% versus 74%, aspirin-clopidogrel versus
aspirin-placebo, respectively; P=0.8). However, in evolving or new
lesions, the mean grade change (1.1+/-1.0 versus 1.6+/-1.1, respectively;
P=0.01) and the proportion of new occlusions (7% versus 22%; P=0.02) were
lower in the aspirin-clopidogrel group. Conclusions-The addition of
clopidogrel to aspirin correlates with less worsening of native coronary
artery disease 1 year after coronary artery bypass grafting. These
findings may help guide post-coronary artery bypass grafting antiplatelet
therapy. Clinical Trial Registration-URL: http://www.clinicaltrials.gov.
Unique identifier: NCT00228423.

<6>
Accession Number
2015327438
Authors
Dizon J.M. Nazif T.M. Hess P.L. Biviano A. Garan H. Douglas P.S. Kapadia
S. Babaliaros V. Herrmann H.C. Szeto W.Y. Jilaihawi H. Fearon W.F. Tuzcu
E.M. Pichard A.D. Makkar R. Williams M. Hahn R.T. Xu K. Smith C.R. Leon
M.B. Kodali S.K.
Institution
(Dizon, Nazif, Biviano, Garan, Hahn, Smith, Leon, Kodali) Department of
Medicine, Columbia University, 222 Westchester Ave, White Plains, NY
10604, United States
(Dizon, Nazif, Biviano, Hahn, Xu, Smith, Leon, Kodali) Cardiovascular
Research Foundation, New York, NY, United States
(Hess, Douglas) Department of Medicine, Duke University, Durham, NC,
United States
(Kapadia, Tuzcu) Cleveland Clinic, Cleveland, OH, United States
(Babaliaros) Emory University School of Medicine, Atlanta, GA, United
States
(Herrmann, Szeto) Hospital of the University of Pennsylvania,
Philadelphia, PA, United States
(Jilaihawi, Makkar) Cedars-Sinai Medical Center, Los Angeles, CA, United
States
(Fearon) Stanford University, Stanford, CA, United States
(Pichard) Medstar Washington Hospital Center, Washington, DC, United
States
(Williams) NYU Langone Medical Center, New York, NY, United States
Title
Chronic pacing and adverse outcomes after transcatheter aortic valve
implantation.
Source
Heart. 101 (20) (pp 1665-1671), 2015. Date of Publication: 10 Aug 2015.
Publisher
BMJ Publishing Group
Abstract
Objective: Many patients undergoing transcatheter aortic valve
implantation (TAVI) have a pre-existing, permanent pacemaker (PPM) or
receive one as a consequence of the procedure. We hypothesised that
chronic pacing may have adverse effects on TAVI outcomes. Methods and
results: Four groups of patients undergoing TAVI in the Placement of
Aortic Transcatheter Valves (PARTNER) trial and registries were compared:
prior PPM (n=586), new PPM (n=173), no PPM (n=1612), and left bundle
branch block (LBBB)/no PPM (n=160). At 1 year, prior PPM, new PPM and
LBBB/no PPM had higher all-cause mortality than no PPM (27.4%, 26.3%,
27.7% and 20.0%, p<0.05), and prior PPM or new PPM had higher
rehospitalisation or mortality/rehospitalisation (p<0.04). By Cox
regression analysis, new PPM (HR 1.38, 1.00 to 1.89, p=0.05) and prior PPM
(HR 1.31, 1.08 to 1.60, p=0.006) were independently associated with 1-year
mortality. Surviving prior PPM, new PPM and LBBB/no PPM patients had lower
LVEF at 1 year relative to no PPM (50.5%, 55.4%, 48.9% and 57.6%, p<0.01).
Prior PPM had worsened recovery of LVEF after TAVI (DELTA=10.0 prior vs
19.7% no PPM for baseline LVEF <35%, p<0.0001; DELTA=4.1 prior vs 7.4% no
PPM for baseline LVEF 35-50%, p=0.006). Paced ECGs displayed a high
prevalence of RV pacing (>88%). Conclusions: In the PARTNER trial, prior
PPM, along with new PPM and chronic LBBB patients, had worsened clinical
and echocardiographic outcomes relative to no PPM patients, and the
presence of a PPM was independently associated with 1-year mortality.
Ventricular dyssynchrony due to chronic RV pacing may be mechanistically
responsible for these findings.

<7>
Accession Number
2015434817
Authors
Fawzy H. Elatafy E. Elkassas M. Elsarawy E. Morsy A. Fawzy A.
Institution
(Fawzy, Elatafy, Morsy, Fawzy) Department of Cardiothoracic Surgery,
Faculty of Medicine, University of Tanta, Tanta 31125, Egypt
(Elkassas) Department of Cardiothoracic Surgery, Faculty of Medicine,
University of Suez Canal, Ismaileya, Egypt
(Elsarawy) Department of Cardiac Surgery, National Heat Institute, Cairo,
Egypt
Title
Can posterior pericardiotomy reduce the incidence of postoperative atrial
fibrillation after coronary artery bypass grafting?.
Source
Interactive Cardiovascular and Thoracic Surgery. 21 (4) (pp 488-491),
2015. Date of Publication: October 2015.
Publisher
Oxford University Press
Abstract
OBJECTIVES Atrial fibrillation (AF) is a common complication that
increases the morbidity after open heart surgery. The pathophysiology is
uncertain, and its prevention remains suboptimal. The aim of this study
was to assess the efficiency of posterior pericardiotomy in decreasing the
incidence of pericardial effusion and postoperative AF. METHODS This
multicentre randomized prospective study included 200 patients who
underwent open heart surgery; coronary artery bypass grafting procedure
between June 2010 and May 2012. A posterior pericardiotomy incision was
done in Group I (n = 100). A longitudinal incision, 4-cm long and 2-cm
width, was made parallel and posterior to the left phrenic nerve,
extending from the left inferior pulmonary vein to the diaphragm. Group II
constituted the control group (n = 100). Postoperative pericardial
effusion was assessed by echocardiography and rhythm follow-up was
monitored daily. RESULTS The incidence of postoperative AF was
significantly lower in the posterior pericardiotomy group than in the
control group (13 vs 30%, P = 0.01). The number of patients with
remarkable postoperative pericardial effusion was significantly lower in
the posterior pericardiotomy group (15 vs 50 patients, P = 0.04).
Tamponade developed in 3 patients in Group II (P = 0.07). There was a
significantly higher incidence of chest drainage in the posterior
pericardiotomy group than in the control group (1041 +/- 549 vs 911 +/-
122 ml; P = 0.04). There was no significant difference between the two
groups regarding hospital stay (8 vs 9 days, P > 0.05). CONCLUSIONS
Posterior pericardiotomy is a simple, safe and effective method for
reducing the incidence of postoperative pericardial effusion and related
atrial fibrillation by improving pericardial drainage after coronary
artery bypass grafting.

<8>
Accession Number
2015441263
Authors
Imazio M. Gaita F. LeWinter M.
Institution
(Imazio) Cardiology Department, Maria Vittoria Hospital, University of
Torino, Via Luigi Cibrario 72, Torino 10141, Italy
(Gaita) University Division of Cardiology, Department of Medical Sciences,
Citta della Salute e Della Scienza, University of Torino, Torino, Italy
(LeWinter) Cardiology Unit, University of Vermont, College of Medicine,
University of Vermont, Medical Center, Burlington, United States
Title
Evaluation and treatment of pericarditis: A systematic review.
Source
JAMA - Journal of the American Medical Association. 314 (14) (pp
1498-1506), 2015. Date of Publication: 13 Oct 2015.
Publisher
American Medical Association
Abstract
IMPORTANCE: Pericarditis is the most common form of pericardial disease
and a relatively common causeof chest pain. OBJECTIVE: To summarize
published evidence on the causes, diagnosis, therapy, prevention, and
prognosis of pericarditis. EVIDENCE REVIEW: A literature search of
BioMedCentral, Google Scholar, MEDLINE, Scopus, and the Cochrane Database
of Systematic Reviews was performed for human studies without language
restriction from January 1, 1990, to August 31, 2015. After literature
review and selection of meta-analyses, randomized clinical trials, and
large observational studies, 30 studies (5 meta-analyses, 10 randomized
clinical trials, and 16 cohort studies) with 7569 adult patients were
selected for inclusion. FINDINGS: The etiology of pericarditis may be
infectious (eg, viral and bacterial) or noninfectious (eg, systemic
inflammatory diseases, cancer, and post-cardiac injury syndromes).
Tuberculosis is a major cause of pericarditis in developing countries but
accounts for less than 5% of cases in developed countries, where
idiopathic, presumed viral causes are responsible for 80% to 90% of cases.
The diagnosis is based on clinical criteria including chest pain, a
pericardial rub, electrocardiographic changes, and pericardial effusion.
Certain features at presentation (temperature >38degreeC [>100.4degreeF],
subacute course, large effusion or tamponade, and failure of nonsteroidal
anti-inflammatory drug [NSAID] treatment) indicate a poorer prognosis and
identify patients requiring hospital admission. The most common treatment
for idiopathic and viral pericarditis in North America and Europe is NSAID
therapy. Adjunctive colchicine can ameliorate the initial episode and is
associated with approximately 50% lower recurrence rates. Corticosteroids
are a second-line therapy for those who do not respond, are intolerant, or
have contraindications to NSAIDs and colchicine. Recurrences may occur in
30% of patients without preventive therapy. CONCLUSIONS AND RELEVANCE:
Pericarditis is the most common form of pericardial disease worldwide and
may recur in as many as one-third of patients who present with idiopathic
or viral pericarditis. Appropriate triage and treatment with NSAIDs may
reduce readmission rates for pericarditis. Treatment with colchicine can
reduce recurrence rates.

<9>
Accession Number
2015445631
Authors
Patel N. Minhas J.S. Chung E.M.L.
Institution
(Patel, Minhas, Chung) Department of Cardiovascular Sciences, University
of Leicester, Leicester LE2 7LX, United Kingdom
(Patel, Chung) Leicester Cardiovascular Biomedical Research Unit,
Glenfield Hospital, Leicester LE3 9QP, United Kingdom
(Minhas) University Hospitals of Leicester NHS Trust, Leicester LE1 5WW,
United Kingdom
(Chung) Department of Medical Physics, University Hospitals of Leicester
NHS Trust, Leicester LE1 5WW, United Kingdom
Title
Risk Factors Associated with Cognitive Decline after Cardiac Surgery: A
Systematic Review.
Source
Cardiovascular Psychiatry and Neurology. 2015 , 2015. Article Number:
370612. Date of Publication: 2015.
Publisher
Hindawi Publishing Corporation (410 Park Avenue, 15th Floor, 287 pmb, New
York NY 10022, United States)
Abstract
Modern day cardiac surgery evolved upon the advent of cardiopulmonary
bypass machines (CPB) in the 1950s. Following this development, cardiac
surgery in recent years has improved significantly. Despite such advances
and the introduction of new technologies, neurological sequelae after
cardiac surgery still exist. Ischaemic stroke, delirium, and cognitive
impairment cause significant morbidity and mortality and unfortunately
remain common complications. Postoperative cognitive decline (POCD) is
believed to be associated with the presence of new ischaemic lesions
originating from emboli entering the cerebral circulation during surgery.
Cardiopulmonary bypass was thought to be the reason of POCD, but
randomised controlled trials comparing with off-pump surgery show
contradictory results. Attention has now turned to the growing evidence
that perioperative risk factors, as well as patient-related risk factors,
play an important role in early and late POCD. Clearly, identifying the
mechanism of POCD is challenging. The purpose of this systematic review is
to discuss the literature that has investigated patient and perioperative
risk factors to better understand the magnitude of the risk factors
associated with POCD after cardiac surgery.

<10>
Accession Number
2015452013
Authors
Breuer T. Emontzpohl C. Coburn M. Benstoem C. Rossaint R. Marx G. Schalte
G. Bernhagen J. Bruells C.S. Goetzenich A. Stoppe C.
Institution
(Breuer, Coburn, Rossaint, Schalte, Stoppe) University Hospital of the
RWTH Aachen, Department of Anaesthesiology, Pauwelsstr. 30, Aachen 52074,
Germany
(Emontzpohl, Benstoem, Goetzenich, Stoppe) University Hospital of the RWTH
Aachen, Department of Thoracic and Cardiovascular Surgery, Aachen, Germany
(Breuer, Marx, Bruells) University Hospital of the RWTH Aachen, Department
of Intensive and Intermediate Care, Pauwelsstr. 30, Aachen 52074, Germany
(Emontzpohl, Bernhagen, Stoppe) University Hospital, RWTH Aachen
University, Institute of Biochemistry and Molecular Cell Biology,
Pauwelsstr. 30, Aachen 52074, Germany
Title
Xenon triggers pro-inflammatory effects and suppresses the
anti-inflammatory response compared to sevoflurane in patients undergoing
cardiac surgery.
Source
Critical Care. 19 (1) , 2015. Date of Publication: October 15, 2015.
Publisher
BioMed Central Ltd.
Abstract
Introduction: Cardiac surgery encompasses various stimuli that trigger
pro-inflammatory mediators, reactive oxygen species and mobilization of
leucocytes. The aim of this study was to evaluate the effect of xenon on
the inflammatory response during cardiac surgery. Methods: This randomized
trial enrolled 30 patients who underwent elective on-pump coronary-artery
bypass grafting in balanced anaesthesia of either xenon or sevoflurane.
For this secondary analysis, blood samples were drawn prior to the
operation, intra-operatively and on the first post-operative day to
measure the pro- and anti-inflammatory cytokines interleukin-6 (IL-6),
interleukin-8/C-X-C motif ligand 8 (IL-8/CXCL8), and interleukin-10
(IL-10). Chemokines such as C-X-C motif ligand 12/ stromal cell-derived
factor-1aalpha (CXCL12/SDF-1aalpha) and macrophage migration inhibitory
factor (MIF) were measured to characterize xenon's perioperative
inflammatory profile and its impact on migration of peripheral blood
mononuclear cells (PBMC). Results: Xenon enhanced the postoperative
increase of IL-6 compared to sevoflurane (Xenon: 90.7 versus sevoflurane:
33.7 pg/ml; p = 0.035) and attenuated the increase of IL-10 (Xenon: 127.9
versus sevoflurane: 548.3 pg/ml; p = 0.028). Both groups demonstrated a
comparable intraoperative increase of oxidative stress (intra-OP: p =
0.29; post-OP: p = 0.65). While both groups showed an intraoperative
increase of the cardioprotective mediators MIF and CXCL12/SDF-1aalpha,
only MIF levels decreased in the xenon group on the first postoperative
day (50.0 ng/ml compared to 23.3 ng/ml; p = 0.012), whereas it remained
elevated after sevoflurane anaesthesia (58.3 ng/ml to 53.6 ng/ml). Effects
of patients' serum on chemotactic migration of peripheral mononuclear
blood cells taken from healthy volunteers indicated a tendency towards
enhanced migration after sevoflurane anaesthesia (p = 0.07). Conclusions:
Compared to sevoflurane, balanced xenon anaesthesia triggers
pro-inflammatory effects and suppresses the anti-inflammatory response in
cardiac surgery patients even though the clinical significance remains
unknown. Trial registration: This clinical trial was approved by the
European Medicines Agency (EudraCT-number: 2010-023942-63) and at
ClinicalTrials.gov (NCT01285271 ; first received: January 24, 2011).

<11>
Accession Number
2015443214
Authors
Wong C.X. Sullivan T. Sun M.T. Mahajan R. Pathak R.K. Middeldorp M. Twomey
D. Ganesan A.N. Rangnekar G. Roberts-Thomson K.C. Lau D.H. Sanders P.
Institution
(Wong, Sullivan, Sun, Mahajan, Pathak, Middeldorp, Twomey, Ganesan,
Rangnekar, Roberts-Thomson, Lau, Sanders) Centre for Heart Rhythm
Disorders, Department of Cardiology, Royal Adelaide Hospital, Adelaide, SA
5000, Australia
Title
Obesity and the risk of incident, post-operative, and post-ablation atrial
fibrillation: A meta-analysis of 626,603 individuals in 51 studies.
Source
JACC: Clinical Electrophysiology. 1 (3) (pp 139-152), 2015. Date of
Publication: June 2015.
Publisher
Elsevier Inc.
Abstract
Objectives The purpose of this study was to quantify the magnitude of
association between incremental increases in body mass index (BMI) and the
development of incident, post-operative, and post-ablation atrial
fibrillation (AF). Background Obesity has been estimated to account for
one-fifth of all AF and approximately 60% of recent increases in
population AF incidence. From a public health perspective, obesity,
therefore, is a modifiable risk factor that could be profitably targeted.
Methods A systematic review and meta-analysis was conducted. Medline and
EMBASE databases were searched for observational studies reporting data on
the association between obesity and incident, post-operative, and
post-ablation AF. Studies were included if they reported or provided data
allowing calculation of risk estimates. Results Data from 51 studies
including 626,603 individuals contributed to this analysis. There were 29%
(odds ratio [OR]: 1.29, 95% confidence interval [CI]: 1.23 to 1.36) and
19% (OR: 1.19, 95% CI: 1.13 to 1.26) greater excess risks of incident AF
for every 5-U BMI increase in cohort and case-control studies,
respectively. Similarly, there were 10% (OR: 1.10, 95% CI: 1.04 to 1.17)
and 13% (OR: 1.13, 95% CI: 1.06 to 1.22) greater excess risks of
post-operative and post-ablation AF for every 5-U increase in BMI,
respectively. Conclusions Incremental increases in BMI are associated with
a significant excess risk of AF in different clinical settings. For every
5-U increase in BMI, there were 10% to 29% greater excess risks of
incident, post-operative, and post-ablation AF. By providing a
comprehensive and reliable quantification of the relationship between
incremental increases in obesity and AF across different clinical
settings, our findings highlight the potential for even moderate
reductions in population body mass indexes to have a significant effect in
mitigating the rising burden of AF.

<12>
Accession Number
2015442865
Authors
Konstam M.A.
Institution
(Konstam) Cardio Vascular Center, Tufts Medical Center, Tufts University
School of Medicine, Box 108, 800 Washington Street, Boston, MA 02111,
United States
Title
Viability, remodeling, and CABG another STICH in the shroud of
observation-based paradigm?.
Source
JACC: Cardiovascular Imaging. 8 (10) (pp 1130-1132), 2015. Date of
Publication: October 2015.
Publisher
Elsevier Inc.

<13>
Accession Number
2015444464
Authors
Abd-Elshafy S.K. Khalaf G.S. Abo-Kerisha M.Z. Ahmed N.T. El-Aziz M.A.A.
Mohamed M.A.
Institution
(Abd-Elshafy) Department of Anesthesia and Intensive Care, Faculty of
Medicine, Assiut University Hospital, Assiut 74111, Egypt
(Khalaf, El-Aziz, Mohamed) Critical Care Nursing Department, Department of
Nursing, United States
(Abo-Kerisha) Clinical Pathology Department, Faculty of Medicine, United
States
(Ahmed) Critical Care and Emergency Nursing Department, Faculty of
Nursing, Alexandria University, Alexandria, Egypt
Title
Not All Sounds Have Negative Effects on Children Undergoing Cardiac
Surgery.
Source
Journal of Cardiothoracic and Vascular Anesthesia. 29 (5) (pp 1277-1284),
2015. Date of Publication: 01 Oct 2015.
Publisher
W.B. Saunders
Abstract
Objective This study was designed to evaluate the role of music therapy on
the level of stress in children undergoing repair of congenital heart
disease. Design Prospective, randomized, double-blind, controlled clinical
trial. Setting Children's university hospital. Participants Fifty children
aged 4 to 12 years undergoing repair of congenital heart disease.
Interventions Patients were randomized into 2 equal groups (control group
and music group); in the control group, patients listened to a blank CD,
and in the music group, patients listened to a recorded CD of music and
songs preferred by the child. Demographic data, clinical data, and
preoperative vital signs were recorded. Baseline stress markers (blood
glucose and cortisol levels) were sampled. Patients were assessed
intraoperatively until extubation for vital signs and stress markers and
after extubation for pain and sedation scales. An interview was conducted
within the first postoperative week with the patients and their parents
for assessment of post-traumatic stress disorder and negative
postoperative behavior changes. Measurements and Main Results There were
no significant differences in demographic characteristics, clinical data,
vital signs, preoperative and at-extubation blood glucose levels, and
preoperative blood cortisol levels between groups. Significant differences
were found between groups in blood glucose levels and cortisol levels at
all intraoperative times, but only in cortisol blood levels at extubation.
Significant differences were found in pain score, sedation score,
occurrence of child post-traumatic stress disorder, and occurrence of
negative postoperative behavior. Conclusion Listening to favorable music
by children undergoing repair for congenital heart disease resulted in
less stress and more relaxation.

<14>
Accession Number
2015438627
Authors
Bin Abdulhak A.A. Baddour L.M. Erwin P.J. Hoen B. Chu V.H. Mensah G.A.
Tleyjeh I.M.
Institution
(Bin Abdulhak) Department of Medicine, School of Medicine, University of
Missouri-Kansas City, Kansas City, MO, United States
(Baddour, Tleyjeh) Division of Infectious Diseases, Mayo Clinic,
Rochester, MN, United States
(Erwin) Mayo Medical Library, Mayo Clinic, Rochester, MN, United States
(Hoen) Department of Infectious Diseases, Dermatology, and Internal
Medicine, University Medical Center of Guadeloupe, Cedex, France
(Chu) Division of Infectious Diseases, Department of Medicine, Duke
University Medical Center, Durham, NC, United States
(Mensah) Center for Translation Research and Implementation Science
(CTRIS), National Heart, Lung, and Blood Institute, National Institutes of
Health, Bethesda, MD, United States
(Tleyjeh) Division of Epidemiology, Mayo Clinic, Rochester, MN, United
States
(Tleyjeh) Department of Medicine, Infectious Diseases Section, King Fahad
Medical City, Riyadh, Saudi Arabia
(Tleyjeh) College of Medicine, Al Faisal University, Riyadh, Saudi Arabia
Title
Global and Regional Burden of Infective Endocarditis, 1990-2010: A
Systematic Review of the Literature.
Source
Global Heart. 9 (1) (pp 131-143), 2014. Date of Publication: 2014.
Publisher
Elsevier
Abstract
Infective endocarditis (IE) is a life-threatening disease associated with
serious complications. The GBD 2010 (Global Burden of Disease, Injuries,
and Risk Factors) study IE expert group conducted a systematic review of
IE epidemiology literature to inform estimates of the burden on IE in 21
world regions in 1990 and 2010. The disease model of IE for the GBD 2010
study included IE death and 2 sequelae: stroke and valve surgery. Several
medical and science databases were searched for IE epidemiology studies in
GBD high-, low-, and middle-income regions published between 1980 and
2008. The epidemiologic parameters of interest were IE incidence,
proportions of IE patients who developed stroke or underwent valve
surgery, and case fatality. Literature searches yielded 1,975 unique
papers, of which 115 published in 10 languages were included in the
systematic review. Eligible studies were population-based (17%),
multicenter hospital-based (11%), and single-center hospital-based studies
(71%). Population-based studies were reported from only 6 world regions.
Data were missing or sparse in many low- and middle-income regions. The
crude incidence of IE ranged between 1.5 and 11.6 cases per 100,000 people
and was reported from 10 countries. The overall mean proportion of IE
patients that developed stroke was 0.158 +/- 0.091, and the mean
proportion of patients that underwent valve surgery was 0.324 +/- 0.188.
The mean case fatality risk was 0.211 +/- 0.104. A systematic review for
the GBD 2010 study provided IE epidemiology estimates for many world
regions, but highlighted the lack of information about IE in low- and
middle-income regions. More complete knowledge of the global burden of IE
will require improved IE surveillance in all world regions.

<15>
Accession Number
2015449628
Authors
De Waal B.A. Buise M.P. Van Zundert A.A.J.
Institution
(De Waal) Department of Anesthesiology, Maastricht University Medical
Centre, P. Debyelaan 25, HX Maastricht 6229, Netherlands
(Buise) Department of Anesthesiology, Catharina Hospital, Postbus 1350, ZA
Eindhoven 5602, Netherlands
(Van Zundert) Discipline of Anesthesiology, University of Queensland,
Faculty of Medicine and Biomedical Sciences, Royal Brisbane and Women's
Hospital, Herston Campus, Brisbane, QLD 4029, Australia
Title
Perioperative statin therapy in patients at high risk for cardiovascular
morbidity undergoing surgery: A review.
Source
British Journal of Anaesthesia. 114 (1) (pp 44-52), 2014. Date of
Publication: 03 Sep 2014.
Publisher
Oxford University Press
Abstract
Statins feature documented benefits for primary and secondary prevention
of cardiovascular disease and are thought to improve perioperative
outcomes in patients undergoing surgery. To assess the clinical outcomes
of perioperative statin treatment in statin-naive patients undergoing
surgery, a systematic review was performed. Studies were included if they
met the following criteria: randomized controlled trials, patients aged
A18 yr undergoing surgery, patients not already on long-term statin
treatment, reported outcomes including at least one of the following:
mortality, myocardial infarction, atrial fibrillation, stroke, and length
of hospital stay. The following randomized clinical trials were excluded:
retrospective studies, trials without surgical procedure, trials without
an outcome of interest, studies with patients on statin therapy before
operation, or papers not written in English. The literature search
revealed 16 randomized controlled studies involving 2275 patients. Pooled
results showed a significant reduction in (i) mortality [risk ratio (RR)
0.53, 95% confidence interval (CI) 0.30.0.94, P=0.03], (ii) myocardial
infarction (RR 0.54, 95% CI 0.38.0.76, P<0.001), (iii) perioperative
atrial fibrillation (RR 0.53, 95% CI 0.43.0.66, P<0.001), and (iv) length
of hospital stay (days, mean difference 20.58, 95% CI -0.79 to -0.37,
P<0.001) in patients treated with a statin. Subgroup analysis in patients
undergoing non-cardiac surgery showed a decrease in the perioperative
incidence of mortality and myocardial infarction. Consequently,
anaesthetists should consider prescribing a standarddose statin before
operation to statin-naive patients undergoing cardiac surgery. However,
there are insufficient data to support final recommendations on
perioperative statin therapy for patients undergoing non-cardiac surgery.

<16>
Accession Number
2015450157
Authors
Guimaraes Marcelino C.A. Rueda Diaz L.J. da Cruz D.M.
Institution
(Guimaraes Marcelino, Rueda Diaz, da Cruz) School of Nursing, Instituto
Dante Pazzanese de Cardiologia, Brazil
(Guimaraes Marcelino, Rueda Diaz, da Cruz) The Brazilian Centre for
Evidence-based Healthcare, Brazil
(Rueda Diaz) Industrial University of Santander, Colombia
Title
The effectiveness of interventions in managing treatment adherence in
adult heart transplant patients: A systematic review.
Source
JBI Database of Systematic Reviews and Implementation Reports. 13 (9) (pp
279-308), 2015. Date of Publication: 2015.
Publisher
Joanna Briggs Institute
Abstract
BACKGROUND: Over the past 20 years, solid organ transplantation has
evolved from experimental treatments to an effective alternative for the
treatment of various diseases, including heart failure. Treatment
non-adherence is a limiting factor for the success of heart transplants. A
systematic review of the evidence is needed to examine the effectiveness
of interventions for managing adherence to treatment in heart transplant
patients. OBJECTIVE: The primary objective of this systematic review was
to synthesize the best available evidence regarding interventions for
managing adherence to pharmacological and non-pharmacological treatments
in heart/heart-lung transplant patients. INCLUSION CRITERIA: Types of
participants:This review considered primary studies that included patients
18 years old or older, who had undergone heart or heart-lung
transplantation (regardless of gender, ethnicity, comorbidities or whether
they had received other treatments or not) who were receiving
pharmacological and non-pharmacological treatments. Types of
interventions: This review considered studies that evaluated the
effectiveness of interventions in managing adherence to pharmacological or
non-pharmacological treatments among adult heart/heart-lung transplant
patients. Primary studies comparing standard care with any type of
intervention to maintain treatment adherence were considered. Types of
studies: This review considered any experimental study design including
randomized controlled trials; other research designs, such as
non-randomized controlled trials and before and after studies, were also
considered for inclusion. Types of outcomes: The primary outcome
considered was patient adherence to pharmacological or non-pharmacological
treatments by means of objective or self-report assessment. SEARCH
STRATEGY: Published and unpublished studies in English, Portuguese and
Spanish were searched in electronic databases. Searches were completed in
January 2014. METHODOLOGICAL QUALITY: Two independent reviewers, using the
standardized critical appraisal instruments from the Joanna Briggs
Institute Meta-Analysis of Statistics Assessment and Review Instrument,
assessed methodological quality. DATA EXTRACTION: Data were extracted
using the standardized data extraction tool from Joanna Briggs Institute
Meta-Analysis of Statistics Assessment and Review Instrument. DATA
SYNTHESIS: Statistical pooling was not possible due to substantial
heterogeneity of the studies; therefore data were presented as a narrative
summary. RESULTS: Three quasi-experimental studies were included in this
review. One study found that a dose reduction of immunosuppressive
medications from a twice-daily to a once-daily regimen had a positive
impact on treatment adherence; one found no significant difference in
treatment adherence between patients who received educational intervention
conducted in a teaching laboratory and those who received standard care;
the third one also reported no significant difference in outcomes between
a multifaceted intervention consisting of internet-based interactive
workshops and standard care. CONCLUSIONS: The current best evidence to
guide decisions regarding interventions to manage treatment adherence in
heart transplant patients is limited. There is weak evidence that
psycho-educational interventions (other than the standard care) has a
positive impact on adherence and that decreasing the complexity of the
treatment regimen by reducing the daily dose of the immunosuppressant drug
improves adherence in heart transplant patients.

<17>
Accession Number
2015390573
Authors
Gosselt A.N.C. Slooter A.J.C. Boere P.R.Q. Zaal I.J.
Institution
(Gosselt, Slooter, Boere, Zaal) University Medical Center Utrecht,
Department of Intensive Care Medicine, Heidelberglaan 100, Utrecht 3584
CX, Netherlands
Title
Risk factors for delirium after on-pump cardiac surgery: A systematic
review.
Source
Critical Care. 19 (1) , 2015. Article Number: 346. Date of Publication:
September 23, 2015.
Publisher
BioMed Central Ltd.
Abstract
Introduction: As evidence-based effective treatment protocols for delirium
after cardiac surgery are lacking, efforts should be made to identify risk
factors for preventive interventions. Moreover, knowledge of these risk
factors could increase validity of etiological studies in which
adjustments need to be made for confounding variables. This review aims to
systematically identify risk factors for delirium after cardiac surgery
and to grade the evidence supporting these associations. Method: A prior
registered systematic review was performed using EMBASE, CINAHL, MEDLINE
and Cochrane from 1990 till January 2015
(http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014007371).
All studies evaluating patients for delirium after cardiac surgery with
cardiopulmonary bypass (CPB) using either randomization or multivariable
data analyses were included. Data was extracted and quality was scored in
duplicate. Heterogeneity impaired pooling of the data; instead a
semi-quantitative approach was used in which the strength of the evidence
was graded based on the number of investigations, the quality of studies,
and the consistency of the association reported across studies. Results:
In total 1462 unique references were screened and 34 were included in this
review, of which 16 (47 %) were graded as high quality. A strong level of
evidence for an association with the occurrence of postoperative delirium
was found for age, previous psychiatric conditions, cerebrovascular
disease, pre-existent cognitive impairment, type of surgery,
peri-operative blood product transfusion, administration of risperidone,
postoperative atrial fibrillation and mechanical ventilation time.
Postoperative oxygen saturation and renal insufficiency were supported by
a moderate level of evidence, and there is no evidence that gender,
education, CPB duration, pre-existent cardiac disease or heart failure are
risk factors. Conclusion: Of many potential risk factors for delirium
after cardiac surgery, for only 11 there is a strong or moderate level of
evidence. These risk factors should be taken in consideration when
designing future delirium prevention strategies trials or when controlling
for confounding in future etiological studies.

<18>
Accession Number
2015440438
Authors
Je H.G. Shuman D.J. Ad N.
Institution
(Je, Shuman, Ad) Inova Heart and Vascular Institute, Falls Church, VA,
United States
Title
A systematic review of minimally invasive surgical treatment for atrial
fibrillation: A comparison of the Cox-Maze procedure, beating-heart
epicardial ablation, and the hybrid procedure on safety and efficacy.
Source
European Journal of Cardio-thoracic Surgery. 48 (4) (pp 531-541), 2015.
Article Number: ezu536. Date of Publication: October 2015.
Publisher
European Association for Cardio-Thoracic Surgery
Abstract
There is a growing trend to perform off-bypass surgical ablation for
atrial fibrillation (AF) because it is perceived to be safer and more
effective than the Cox-Maze procedure with cardiopulmonary bypass (CPB)
support. In this systematic review, we compared three minimally invasive
stand-alone surgical ablation procedures for AF: the endocardial Cox-Maze
procedure, epicardial surgical ablation and a hybrid epicardial surgical
and catheter-based endocardial ablation procedure (hybrid procedure).
Relevant studies were identified in MEDLINE and the Cochrane Database of
Systematic Reviews according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guidelines. From 565 initial
studies, 37 were included in this review. The total number of patients
across all studies was 1877 (range 10-139). Two studies reported on
endocardial Cox-Maze procedures (n = 145), 26 reported on epicardial
surgical ablation (n = 1382) and 9 reported on hybrid surgical ablation (n
= 350). For minimally invasive Cox-Maze, epicardial and hybrid groups,
operative mortality rates were 0, 0.5 and 0.9%, perioperative permanent
pacemaker insertion rates were 3.5, 2.7 and 1.5%, incidence of conversion
to median sternotomy was 0, 2.4 and 2.5%, and reoperation for bleeding was
1.0, 1.5 and 2.2%, with mean length of stay (days) of 5.4, 6.0 and 4.6,
respectively. At 12 months, rates of sinus rhythm restoration were 93, 80
and 70%, and sinus restoration without anti-arrhythmic medications was 87,
72 and 71%, for Cox-Maze, epicardial and hybrid procedures, respectively.
Of the three procedures, the minimally invasive Cox-Maze procedure with
CPB support was most effective for the treatment of stand-alone AF and had
important safety advantages in conversion to sternotomy and major
bleeding. The minimally invasive Cox-Maze procedure with CPB support also
demonstrated the potential for a higher success rate 12 months following
the procedure.

<19>
[Use Link to view the full text]
Accession Number
26035251
Authors
Moerman A.T. Vanbiervliet V.M. Van Wesemael A. Bouchez S.M. Wouters P.F.
De Hert S.G.
Institution
(Moerman, Vanbiervliet, Van Wesemael, Bouchez, Wouters, De Hert) From the
Department of Anesthesiology, Ghent University Hospital, Ghent, Belgium
Title
Assessment of Cerebral Autoregulation Patterns with Near-infrared
Spectroscopy during Pharmacological-induced Pressure Changes.
Source
Anesthesiology. 123 (2) (pp 327-335), 2015. Date of Publication: 01 Aug
2015.
Abstract
BACKGROUND: Previous work has demonstrated paradoxical increases in
cerebral oxygen saturation (ScO2) as blood pressure decreases and
paradoxical decreases in ScO2 as blood pressure increases. It has been
suggested that these paradoxical responses indicate a functional cerebral
autoregulation mechanism. Accordingly, the authors hypothesized that if
this suggestion is correct, paradoxical responses will occur exclusively
in patients with intact cerebral autoregulation.
METHODS: Thirty-four patients undergoing elective cardiac surgery were
included. Cerebral autoregulation was assessed with the near-infrared
spectroscopy-derived cerebral oximetry index (COx), computed by
calculating the Spearman correlation coefficient between mean arterial
pressure and ScO2. COx less than 0.30 was previously defined as functional
autoregulation. During cardiopulmonary bypass, 20% change in blood
pressure was accomplished with the use of nitroprusside for decreasing
pressure and phenylephrine for increasing pressure. Effects on COx were
assessed. Data were analyzed using two-way ANOVA, Kruskal-Wallis test, and
Wilcoxon and Mann-Whitney U test.
RESULTS: Sixty-five percent of patients had a baseline COx less than 0.30,
indicating functional baseline autoregulation. In 50% of these patients (n
= 10), COx became highly negative after vasoactive drug administration
(from -0.04 [-0.25 to 0.16] to -0.63 [-0.83 to -0.26] after administration
of phenylephrine, and from -0.05 [-0.19 to 0.17] to -0.55 [-0.94 to -0.35]
after administration of nitroprusside). A negative COx implies a decrease
in ScO2 with increase in pressure and, conversely, an increase in ScO2
with decrease in pressure.
CONCLUSIONS: In this study, paradoxical changes in ScO2 after
pharmacological-induced pressure changes occurred exclusively in patients
with intact cerebral autoregulation, corroborating the hypothesis that
these paradoxical responses might be attributable to a functional cerebral
autoregulation.

<20>
Accession Number
25071414
Authors
Fleischer S. Berg A. Behrens J. Kuss O. Becker R. Horbach A. Neubert T.R.
Institution
(Fleischer) Institute of Health and Nursing Science, Medical Faculty,
Martin-Luther-University Halle-Wittenberg, Halle, Germany
(Berg) Institute of Health and Nursing Science, Medical Faculty,
Martin-Luther-University Halle-Wittenberg, Halle, Germany
(Behrens) Institute of Health and Nursing Science, Medical Faculty,
Martin-Luther-University Halle-Wittenberg, Halle, Germany
(Kuss) Institute of Medical Epidemiology, Biostatistics, and Informatics,
Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle, Germany
(Becker) Stadtisches Klinikum Munchen GmbH Akademie, Munich, Germany
(Horbach) Sana Herzchirurgische Klinik Stuttgart, Stuttgart, Germany ;
Department 4: Health and Social Work, University of Applied Sciences,
Frankfurt/Main, Germany ; Hessian Institute of Nursing Research (HessIP),
Franfurt/Main, Germany
(Neubert) Department of Nursing Research, University Hospital Giessen and
Marburg, Location Marburg, Germany ; Institute for Theoretical
Surgery/Department of Visceral, Thoracic and Vascular Surgery, University
Hospital Giessen and Marburg, Location Marburg, Germany
Title
Does an additional structured information program during the intensive
care unit stay reduce anxiety in ICU patients?: a multicenter randomized
controlled trial.
Source
BMC anesthesiology. 14 (pp 48), 2014. Date of Publication: 2014.
Abstract
BACKGROUND: Communication and information in order to reduce anxiety in
the intensive care unit (ICU) has been described as area needing
improvement. Therefore, the aim of this trial was to evaluate whether a
structured information program that intensifies information given in
standard care process reduces anxiety in ICU patients.
METHODS: Multicenter, two-armed, non-blinded, parallel-group randomized
controlled trial in hospitals in the cities of Marburg, Halle, and
Stuttgart (Germany). The trial was performed in cardiac surgery, general
surgery, and internal medicine ICUs. Two-hundred and eleven elective and
non-elective ICU patients were enrolled in the study (intervention group,
n=104; control group, n=107). The experimental intervention comprised a
single episode of structured oral information that was given in addition
to standard care and covered two main parts: (1) A more standardized part
about predefined ICU specific aspects - mainly procedural, sensory and
coping information, and (2) an individualized part about fears and
questions of the patient. The control group received a non-specific
episodic conversation of similar length additional to standard care. Both
conversations took place at the beginning of the ICU stay and lasted 10-15
minutes. Study nurses administered both interventions. The primary outcome
ICU-related anxiety (CINT-Score, 0-100 pts., higher scores indicate higher
anxiety) was assessed after admission to a regular ward.
RESULTS: The primary outcome could be measured in 82 intervention group
participants and 90 control group participants resulting in mean values of
20.4 (SD 14.4) compared to 20.8 (SD 14.7) and a mean difference of -0.2
(CI 95% -4.5 to 4.1).
CONCLUSIONS: A structured information intervention additional to standard
care during ICU stay had no demonstrated additional benefit compared to an
unspecific communication of similar duration. Reduction of anxiety in ICU
patients will probably require more continuous approaches to information
giving and communication.
TRIAL REGISTRATION: ClinicalTrials.gov NCT00764933.

<21>
Accession Number
23958073
Authors
Kus A. Hosten T. Gurkan Y. Gul Akgul A. Solak M. Toker K.
Institution
(Kus) Department of Anesthesiology and Reanimation, Medical Faculty of
Kocaeli University, Umuttepe, Kocaeli, Turkey. Electronic address:
(Hosten) Department of Anesthesiology and Reanimation, Medical Faculty of
Kocaeli University, Umuttepe, Kocaeli, Turkey
(Gurkan) Department of Anesthesiology and Reanimation, Medical Faculty of
Kocaeli University, Umuttepe, Kocaeli, Turkey
(Gul Akgul) Department of Thoracic Surgery, Medical Faculty of Kocaeli
University, Umuttepe, Kocaeli, Turkey
(Solak) Department of Anesthesiology and Reanimation, Medical Faculty of
Kocaeli University, Umuttepe, Kocaeli, Turkey
(Toker) Department of Anesthesiology and Reanimation, Medical Faculty of
Kocaeli University, Umuttepe, Kocaeli, Turkey
Title
A comparison of the EZ-Blocker with a Cohen Flex-Tip blocker for one-lung
ventilation.
Source
Journal of cardiothoracic and vascular anesthesia. 28 (4) (pp 896-899),
2014. Date of Publication: 01 Aug 2014.
Abstract
OBJECTIVES: The EZ-Blocker (IQ Medical Ventures BV, Rotterdam,
Netherlands) is a newly designed device for one-lung ventilation. The aim
of this study was to compare the effectiveness of the Cohen Flex-Tip
bronchial blocker (Cook, Bloomington, IN) and the EZ-Blocker for one-lung
ventilation during thoracic surgery.
DESIGN: Randomized and prospective.
SETTING: A university hospital.
PARTICIPANTS: This study included 40 patients undergoing thoracic surgical
procedures.
INTERVENTIONS: Patients were assigned to 2 study groups: Patients who
received the Cohen Flex-Tip blocker were assigned to the Cohen group, and
patients who received the EZ-Blocker were assigned to the EZ group. In
both groups, fiberoptic guidance was used during placement of the
bronchial blockers. Comparisons between the groups included the time to
correct placement, the incidence of malpositioning, and the satisfaction
level of the surgeon (good, fair, poor).
MEASUREMENTS AND MAIN RESULTS: One-lung ventilation was achieved
successfully for all patients. The time to correct placement (mean+/-SD)
was significantly shorter in the EZ group (146+/-56 seconds) compared with
the Cohen group (241+/-51 seconds; p=0.01). The incidence of
malpositioning was significantly lower in the EZ group compared with the
Cohen group (p=0.018). Surgeon satisfaction was similar in both groups.
CONCLUSIONS: In this study, both bronchial blockers provided similar
surgical exposure during thoracic procedures. The EZ-Blocker had a shorter
time to correct positioning and less frequent intraoperative
malpositioning.

<22>
Accession Number
24447503
Authors
Al Shehri A.M. El-Tahan M.R. Al Metwally R. Qutub H. El Ghoneimy Y.F.
Regal M.A. Zien H.
Institution
(Al Shehri) Department of Cardiology, King Fahd Hospital of the University
of Dammam, Al Khubar, Saudi Arabia
(El-Tahan) Department of Anaesthesia and Surgical ICU, King Fahd Hospital
of the University of Dammam, Al Khubar, Saudi Arabia. Electronic address:
mohamedrefaateltahan@yahoo.com
(Al Metwally) Department of Anaesthesia and Surgical ICU, King Fahd
Hospital of the University of Dammam, Al Khubar, Saudi Arabia
(Qutub) Department of Pulmonology and Intensive Care Unit, King Fahd
Hospital of the University of Dammam, Al Khubar, Saudi Arabia
(El Ghoneimy) Cardiothoracic Surgery, King Fahd Hospital of the University
of Dammam, Al Khubar, Saudi Arabia
(Regal) Cardiothoracic Surgery, King Fahd Hospital of the University of
Dammam, Al Khubar, Saudi Arabia
(Zien) Department of Anaesthesia and Surgical ICU, King Fahd Hospital of
the University of Dammam, Al Khubar, Saudi Arabia
Title
Right ventricular function during one-lung ventilation: effects of
pressure-controlled and volume-controlled ventilation.
Source
Journal of cardiothoracic and vascular anesthesia. 28 (4) (pp 880-884),
2014. Date of Publication: 01 Aug 2014.
Abstract
OBJECTIVES: To test the effects of pressure-controlled (PCV) and
volume-controlled (VCV) ventilation during one-lung ventilation (OLV) for
thoracic surgery on right ventricular (RV) function.
DESIGN: A prospective, randomized, double-blind, controlled, crossover
study.
SETTING: A single university hospital.
PARTICIPANTS: Fourteen pairs of consecutive patients scheduled for
elective thoracotomy.
INTERVENTIONS: Patients were assigned randomly to ventilate the dependent
lung with PCV or VCV mode, each in a randomized crossover order using
tidal volume of 6 mL/kg, I: E ratio 1: 2.5, positive end-expiratory
pressure (PEEP) of 5 cm H2O and respiratory rate adjusted to maintain
normocapnia.
MEASUREMENTS AND MAIN RESULTS: Intraoperative changes in RV function
(systolic and early diastolic tricuspid annular velocity (TAV),
end-systolic volume (ESV), end-diastolic volume (EDV) and fractional area
changes (FAC)), airway pressures, compliance and oxygenation index were
recorded. The use of PCV during OLV resulted in faster systolic
(10.1+/-2.39 vs. 5.8+/-1.67 cm/s, respectively), diastolic TAV (9.2+/-1.99
vs. 4.6+/-1.42 cm/s, respectively) (p<0.001) and compliance and lower ESV,
EDV and airway pressures (p<0.05) than during the use of VCV. Oxygenation
indices were similar during the use of VCV and PCV.
CONCLUSIONS: The use of PCV offers more improved RV function than the use
of VCV during OLV for open thoracotomy. These results apply specifically
to younger patients with good ventricular and pulmonary functions.

<23>
Accession Number
24094562
Authors
Wang S. Zhang J. Cheng H. Yin J. Liu X.
Institution
(Wang) Department of Anesthesiology, Wuhu Second People's Hospital, Wuhu
City, Anhui, China. Electronic address: wuhuwsl@163.com
(Zhang) Department of Anesthesiology, Wuhu Second People's Hospital, Wuhu
City, Anhui, China
(Cheng) Department of Anesthesiology, Wuhu Second People's Hospital, Wuhu
City, Anhui, China
(Yin) Department of Anesthesiology, Wuhu Second People's Hospital, Wuhu
City, Anhui, China
(Liu) Department of Anesthesiology, Wuhu Second People's Hospital, Wuhu
City, Anhui, China
Title
A clinical evaluation of the ProSeal laryngeal mask airway with a Coopdech
bronchial blocker for one-lung ventilation in adults.
Source
Journal of cardiothoracic and vascular anesthesia. 28 (4) (pp 900-903),
2014. Date of Publication: 01 Aug 2014.
Abstract
OBJECTIVE: To compare the effects of one-lung ventilation (OLV) offered by
ProSeal laryngeal mask airway (PLMA) or endotracheal tube (ETT) with
Coopdech bronchial blocker (BB) in adult patients undergoing thoracoscopic
procedures, and also to evaluate the feasibility and security of
application of PLMA with Coopdech BB for OLV.
DESIGN: Prospective, randomized study.
SETTING: A local hospital.
PARTICIPANTS: One-hundred adult patients undergoing thoracoscopic
procedures.
INTERVENTIONS: PLMA with Coopdech BB (group PLMA-BB, n=50) or ETT with
Coopdech BB (group ETT-BB, n=50) was used for OLV.
MEASUREMENTS AND MAIN RESULTS: There were no differences between the
groups in terms of time of OLV, time of correct placement of the BB, or
cases of BB dislodgement. Forty-seven patients succeeded in OLV in the
PLMA-BB group (94%), all patients succeeded in OLV in the ETT-BB group
(100%), and there was no significant difference in success rate between
groups (p>0.05). Arterial oxygen tension, end-expiration tidal volume, and
peak airway pressure showed no statistical difference in TLV or 30 minutes
after the initiation of OLV between 2 groups (p>0.05).
CONCLUSION: The combined use of PLMA and Coopdech BB in adult patients can
achieve adequate OLV for brief thoracoscopic procedures.

<24>
Accession Number
24480179
Authors
Kang W.-S. Kim S.-H. Chung J.W.
Institution
(Kang) Department of Anaesthesiology and Pain Medicine, Konkuk University
Hospital, Konkuk University Medical Center; Research Institute of Medical
Science, Konkuk University School of Medicine, Seoul, Korea
(Kim) Department of Anaesthesiology and Pain Medicine, Konkuk University
Hospital, Konkuk University Medical Center; Research Institute of Medical
Science, Konkuk University School of Medicine, Seoul, Korea. Electronic
address: yshkim75@daum.net
(Chung) Department of Thoracic and Cardiovascular Surgery, Cleveland
Clinic, Cleveland, Ohio
Title
Comparison of pulmonary gas exchange according to intraoperative
ventilation modes for mitral valve repair surgery via thoracotomy with
one-lung ventilation: a randomized controlled trial.
Source
Journal of cardiothoracic and vascular anesthesia. 28 (4) (pp 908-913),
2014. Date of Publication: 01 Aug 2014.
Abstract
OBJECTIVE: Impaired pulmonary gas exchange after cardiac surgeries with
cardiopulmonary bypass (CPB) often occurs, and the selection of mechanical
ventilation mode, pressure-controlled ventilation (PCV) or
volume-controlled ventilation (VCV), may be important for preventing
hypoxia and improving oxygenation. The authors hypothesized that patients
with PCV would show better oxygenation, compared with VCV, during one-lung
ventilation (OLV) for mitral valve repair surgery (MVP) via thoracotomy.
DESIGN: Randomized controlled trial.
SETTING: University teaching hospital.
PARTICIPANTS: Sixty patients in each group.
INTERVENTIONS: MVP was performed using thoracotomy with OLV by PCV or VCV.
MEASUREMENTS AND MAIN RESULTS: Arterial partial pressure of oxygen (PaO2)
and fraction of inspired oxygen (FIO2) were measured before anesthesia
induction (T0), at skin incision (T1), after administration of heparin
(T2), at 30 minutes after CPB weaning (T3), just before departure from the
operating room to the intensive care unit (ICU) (T4), and 1 hour after ICU
admission (T5), and PaO2/FIO2 ratio was calculated. Peak inspiratory
pressure (PIP) and mean inspiratory pressure (Pmean) were recorded at T1,
T2, T3, and T4. No significant difference was noted in the PaO2/FIO2 ratio
between the groups at any measured point. PIP in the PCV group at all
measured points was lower than that in the VCV group (T1, p<0.001; T2,
p<0.001; T3, p<0.001; T4, p=0.025, respectively). Pmean was not different
between the two groups at any measured point.
CONCLUSIONS: PCV during OLV in patients undergoing MVP via a thoracotomy
with OLV showed lower PIP compared with VCV, but this did not improve
pulmonary gas exchange.

<25>
Accession Number
24686029
Authors
Zhang W. Fang C. Li J. Geng Q.-T. Wang S. Kang F. Pan J.-H. Chai X.-Q. Wei
X.
Institution
(Zhang) Department of Anesthesiology, Anhui Medical University Affiliated
Auhui Provincial Hospital, People's Republic of China
(Fang) Department of Anesthesiology, Anhui Medical University Affiliated
Auhui Provincial Hospital, People's Republic of China. Electronic address:
doctor_fc@163.com
(Li) Department of Anesthesiology, Anhui Medical University Affiliated
Auhui Provincial Hospital, People's Republic of China
(Geng) Department of Anesthesiology, Anhui Medical University Affiliated
Auhui Provincial Hospital, People's Republic of China
(Wang) Department of Anesthesiology, Anhui Medical University Affiliated
Auhui Provincial Hospital, People's Republic of China
(Kang) Department of Anesthesiology, Anhui Medical University Affiliated
Auhui Provincial Hospital, People's Republic of China
(Pan) Department of Anesthesiology, Anhui Medical University Affiliated
Auhui Provincial Hospital, People's Republic of China
(Chai) Department of Anesthesiology, Anhui Medical University Affiliated
Auhui Provincial Hospital, People's Republic of China
(Wei) Department of Anesthesiology, Anhui Medical University Affiliated
Auhui Provincial Hospital, People's Republic of China
Title
Single-dose, bilateral paravertebral block plus intravenous sufentanil
analgesia in patients with esophageal cancer undergoing combined
thoracoscopic-laparoscopic esophagectomy: a safe and effective
alternative.
Source
Journal of cardiothoracic and vascular anesthesia. 28 (4) (pp 966-972),
2014. Date of Publication: 01 Aug 2014.
Abstract
OBJECTIVE: Paravertebral block (PVB) has been shown to be an ideal aid for
analgesia after thoracic or abdominal surgery. The authors studied the
safety and efficacy of the single-dose and bilateral ultrasound-guided
(USG)-PVB before combined thoracoscopic-laparoscopic esophagectomy (TLE)
along with intravenous sufentanil analgesia as a method of pain relief in
comparison with intravenous sufentanil as a sole analgesic agent.
DESIGN: Prospective, randomized study.
SETTING: Single university hospital.
PARTICIPANTS: Fifty-two patients undergoing TLE.
INTERVENTIONS: A USG-PVB was performed before surgery using a solution of
30 mL of 0.5% ropivacaine by 3 injections of 10 mL each at the right T5
and bilateral T8 (PVB group, n=26) or the saline injection of 10 mL at
every site (control group, n=26).
MEASUREMENTS AND MAIN RESULTS: Successful PVBs were achieved in all
patients of the PVB group. Intraoperative mean remifentanil usage and
end-tidal sevoflurane concentration were lower in the PVB group (p<0.001).
Hemodynamic parameters were stable in both groups. Postoperative pain
scores both at rest and on coughing were lower during the first 8 hours in
the PVB group than those in the control group (p<0.05). Cumulative
sufentanil consumption delivered by patient-controlled analgesia (PCA) was
significantly lower in the PVB group at all time points (p<0.05).
Postoperative pulmonary function was better at the third postoperative day
in the PVB group (p<0.05), with quicker hospital discharge and lower
hospital costs (p<0.05).
CONCLUSIONS: The single-dose and bilateral PVB given before TLE combined
with sufentanil may provide better postoperative analgesia and early
discharge in patients undergoing TLE.

<26>
Accession Number
24231197
Authors
Yoo J.Y. Kim D.H. Choi H. Kim K. Chae Y.J. Park S.Y.
Institution
(Yoo) Department of Anesthesiology and Pain Medicine, Ajou University,
School of Medicine, Suwon, Korea
(Kim) Department of Anesthesiology and Pain Medicine, Ajou University,
School of Medicine, Suwon, Korea
(Choi) Department of Thoracic and Cardiovascular Surgery, Ajou University,
School of Medicine, Suwon, Korea
(Kim) Department of Anesthesiology and Pain Medicine, Ajou University,
School of Medicine, Suwon, Korea
(Chae) Department of Anesthesiology and Pain Medicine, Ajou University,
School of Medicine, Suwon, Korea
(Park) Department of Anesthesiology and Pain Medicine, Ajou University,
School of Medicine, Suwon, Korea. Electronic address: anepark@hanmail.net
Title
Disconnection technique with a bronchial blocker for improving lung
deflation: a comparison with a double-lumen tube and bronchial blocker
without disconnection.
Source
Journal of cardiothoracic and vascular anesthesia. 28 (4) (pp 904-907),
2014. Date of Publication: 01 Aug 2014.
Abstract
OBJECTIVE: One-lung ventilation (OLV) is accomplished with a double-lumen
tube (DLT) or a bronchial blocker (BB). The authors compared the
effectiveness of lung collapse using DLT, BB, and BB with the
disconnection technique.
DESIGN: Prospective, randomized, blind trial.
SETTING: A university hospital.
PARTICIPANTS: Fifty-two patients undergoing elective pneumothorax surgery.
INTERVENTIONS: Patients were assigned randomly to 1 of 3 groups: The DLT
group (group 1), the BB group (group 2), and the BB with the disconnection
technique group (group 3). The authors modified the disconnection
technique in group 3 as follows: (1) turned off the ventilator and opened
the adjustable pressure-limiting valve, allowing both lungs to collapse
and (2) after loss of the CO2 trace on the capnograph, inflated the
blocker cuff and turned on the ventilator, allowing only dependent-lung
ventilation.
MEASUREMENTS AND MAIN RESULTS: Five and ten minutes after OLV, the degree
of lung collapse was assessed by the surgeon, who was blinded to the
isolation technique. The quality of lung collapse at 5 and 10 minutes was
significantly better in groups 1 and 3 than in group 2. No significant
differences were observed for the degree of lung collapse at any time
point between groups 1 and 3. The average time for loss of the CO2 trace
on the capnograph was 32.3+/-7.0 seconds in group 3.
CONCLUSIONS: A BB with spontaneous collapse took longer to deflate and did
not provide equivalent surgical exposure to the DLT. The disconnection
technique could be helpful to accelerate lung collapse with a BB.

Saturday, October 24, 2015

EMBASE Cardiac Update AutoAlert: EPICORE Cardiac Surgery Blogger2

Total documents retrieved: 30

Results Generated From:
Embase <1980 to 2015 Week 43>
Embase (updates since 2015-10-15)
Embase <1980 to 2015 Week 43>
Embase (updates since 2015-10-15)


<1>
Accession Number
2015707352
Authors
Sezai A. Soma M. Nakata K.-I. Osaka S. Ishii Y. Yaoita H. Hata H. Shiono
M.
Institution
(Sezai, Nakata, Osaka, Ishii, Yaoita, Hata, Shiono) Department of
Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan
(Soma) Department of General Medicine, Nihon University School of
Medicine, Tokyo, Japan
Title
Comparison of febuxostat and allopurinol for hyperuricemia in cardiac
surgery patients with chronic kidney disease (NU-FLASH trial for CKD).
Source
Journal of Cardiology. 66 (4) (pp 298-303), 2015. Date of Publication: 01
Oct 2015.
Publisher
Japanese College of Cardiology (Nippon-Sinzobyo-Gakkai)
Abstract
Background: The NU-FLASH trial demonstrated that febuxostat was more
effective for hyperuricemia than allopurinol. This time, we compared these
medications in patients with chronic kidney disease (CKD) from the
NU-FLASH trial. Methods and results: In the NU-FLASH trial, 141 cardiac
surgery patients with hyperuricemia were randomized to a febuxostat group
or an allopurinol group. This study analyzed 109 patients with an
estimated glomerular filtration rate (eGFR) <60mL/min/1.73m<sup>2</sup>,
and also analyzed 87 patients with stage 3 CKD. The primary endpoint was
the serum uric acid level. Secondary endpoints included serum creatinine,
urinary albumin, cystatin-C, oxidized low-density lipoprotein,
eicosapentaenoic acid/arachidonic acid ratio, total cholesterol,
triglycerides, low-density lipoprotein, high-density lipoprotein, and
high-sensitivity C-reactive protein.Among patients with an
eGFR<60mL/min/1.73m<sup>2</sup>, uric acid levels were significantly lower
in the febuxostat group than the allopurinol group from 1 month of
treatment onward. The serum creatinine, urinary albumin, cystatin-C,
oxidized low-density lipoprotein, eicosapentaenoic acid/arachidonic acid
ratio, and high-sensitivity C-reactive protein were also significantly
lower in the febuxostat group. Similar results were obtained in the
patients with stage 3 CKD. Conclusion: In cardiac surgery patients with
renal dysfunction, febuxostat reduced uric acid earlier than allopurinol,
had a stronger renoprotective effect than allopurinol, and also had
superior antioxidant and anti-inflammatory effects.

<2>
Accession Number
2014909153
Authors
Okajima H. Tanaka O. Ushio M. Higuchi Y. Nagai Y. Iijima K. Horikawa Y.
Ijichi K.
Institution
(Okajima, Tanaka, Higuchi, Nagai, Iijima, Ijichi) Department of
Anesthesiology, Nishi-Kobe Medical Center, 5-7-1 Kojidai, Nishiku, Kobe,
Hyogo 651-2273, Japan
(Ushio) Department of Anesthesiology, Kakogawa West City Hospital, 384-1
Yonedachohiratsu, Kakogawa, Hyogo 675-8611, Japan
(Horikawa) Department of Anesthesiology, Hyogo Brain and Heart Center At
Himeji, 520 Saisyo-ko, Himeji-city, Hyogo 670-0981, Japan
Title
Ultrasound-guided continuous thoracic paravertebral block provides
comparable analgesia and fewer episodes of hypotension than continuous
epidural block after lung surgery.
Source
Journal of Anesthesia. 29 (3) (pp 373-378), 2015. Date of Publication: 15
Nov 2015.
Publisher
Springer-Verlag Tokyo
Abstract
Purpose: Both paravertebral block (PVB) and thoracic epidural block (TEB)
are recommended for postoperative pain relief after lung surgery. The
addition of fentanyl to the anesthetic solution became popular for TEB
because of the stronger effects; however, there have been few comparable
trials about the addition of fentanyl to PVB. The purpose of this study
was thus to compare postoperative analgesia, side effects, and
complications between ultrasound-guided PVB (USG-PVB) and TEB with the
addition of fentanyl to ropivacaine after lung surgery. Methods: We
examined 90 consecutive patients (age 18-75 years) scheduled for
video-assisted thoracic surgery (VATS). In both groups, all blocks (four
blocks in USG-PVB and one block in TEB) and one catheter insertion were
performed preoperatively. Continuous postoperative infusion (0.1 %
ropivacaine plus fentanyl at 0.4 mg/day) was undertaken for 36 h in both
groups. The recorded data included the verbal rating scale (VRS) for pain,
blood pressure, side effects, complications for 2 days, and overall
satisfaction score. Results: There was no difference in the frequency of
taking supplemental analgesics (twice or more frequently), or in VRS.
Hypotension occurred significantly more frequently in TEB (n = 7/33) than
in PVB (n = 1/36) (P = 0.02); on the other hand, the incidences of PONV
and pruritus, as well as overall satisfaction score, were similar. There
were no complications in both groups; however, the catheters migrated
intrathoracically in four patients in PVB. Conclusion: USG-PVB achieved
similar pain relief and lowered the incidence of hypotension compared with
TEB. We conclude that both blocks with the same concentration of
ropivacaine and fentanyl can provide adequate postoperative analgesia for
VATS.

<3>
Accession Number
2015119433
Authors
Wang J. Gu C. Gao M. Yu W. Yu Y.
Institution
(Wang, Gu, Gao, Yu, Yu) Department of Cardiac Surgery, Beijing An Zhen
Hospital, Capital Medical University, Beijing 100029, China
Title
Preoperative Statin Therapy and Renal Outcomes After Cardiac Surgery: A
Meta-analysis and Meta-regression of 59,771 Patients.
Source
Canadian Journal of Cardiology. 31 (8) (pp 1051-1060), 2015. Date of
Publication: 01 Aug 2015.
Publisher
Pulsus Group Inc.
Abstract
Background: The purpose of this study was to investigate the effects of
preoperative statin therapy (PST) on short- and long-term renal
dysfunction after cardiac surgery. Methods: We searched for reports that
investigated the effects of PST on renal outcomes after cardiac surgery in
the electronic literature databases PubMed, Ovid, and Elsevier. Results:
Twenty-six reports including 59,771 patients were selected for
meta-analysis. The meta-analysis revealed that PST significantly reduced
the incidence of postoperative renal dysfunction (odds ratio [OR], 0.89;
95% confidence interval [CI], 0.84-0.95; P < 0.0001) without significant
heterogeneity (I<sup>2</sup> = 28.1%; P = 0.093). PST also significantly
reduced the need for postoperative renal replacement therapy (OR = 0.76;
95% CI, 0.62-0.92; z = 2.77; P = 0.006); particularly in the subgroup of
patients who underwent isolated coronary artery bypass grafting, the rate
of renal replacement therapy was reduced by 56% (OR, 0.44; 95% CI,
0.30-0.66; z = 4.08; P < 0.0001) with low heterogeneity (I<sup>2</sup> =
18.7%; P = 0.297). Meta-analysis for the outcome of acute kidney injury
(AKI) revealed that PST reduced the incidence of postoperative AKI by 13%
(OR, 0.87; 95% CI, 0.80-0.94; P = 0.001) and 7% (OR, 0.93; 95% CI,
0.86-0.99; P = 0.031), respectively, for subgroups of patients whose AKI
was evaluated using the Acute Kidney Injury Network (AKIN) or the Risk,
Injury, Failure, Loss, and End Stage (RIFLE) criteria, without significant
heterogeneity for either. Conclusions: PST might be a promising therapy to
reduce renal complications after cardiac surgery although large-scaled
randomized controlled trials are needed to further verify the conclusion.

<4>
Accession Number
2015312548
Authors
Borde D. Asegaonkar B. Apsingekar P. Khade S. Futane S. Khodve B.
Annachatre A. Puranik M. Borgaonkar V. Belapurkar Y. Joshi S.
Institution
(Borde, Asegaonkar, Apsingekar, Khade, Futane, Khodve, Annachatre) Ozone
Anesthesia Group, Department of Cardiac Surgery, Aurangabad, M.S, India
(Puranik) Department of Cardiac Surgery, Aurangabad, M.S, India
(Borgaonkar) Department of Surgery, Seth Nandlad Dhoot Hospital,
Aurangabad, M.S, India
(Belapurkar) Department of Cardiac Surgery, M.G.M. Medical College and
Hospital, Aurangabad, M.S., India
(Joshi) Department of Anesthesia, Sri Jayadeva Institute of Cardiovascular
Sciences and Research, Bengaluru, India
Title
Risk Stratification in Off-Pump Coronary Artery Bypass (OPCAB) Surgery -
Role of EuroSCORE II.
Source
Journal of Cardiothoracic and Vascular Anesthesia. 29 (5) (pp 1167-1171),
2015. Date of Publication: 01 Oct 2015.
Publisher
W.B. Saunders
Abstract
Objectives To evaluate the EuroSCORE II for risk stratification in
patients undergoing off-pump coronary artery bypass (OPCAB) surgery.
Design A retrospective observational study. Setting Two tertiary care
hospitals. Participants Participants were 1,211 patients undergoing OPCAB
surgery. Interventions No interventions were implemented. Measurements and
Main Results The EuroSCORE II estimated the operative risk for each
patient. The calibration of the scoring system was assessed using the
Hosmer Lemeshow test, and the discriminative capacity was estimated with
area under receiver operating characteristic curves. The incidence,
patient characteristics, causes of intraoperative conversion to on-pump
coronary artery bypass (ONCAB), and outcome were studied. The all-cause
in-hospital mortality was 2.39%. Predicted mortality with the EuroSCORE II
was 2.03+/-1.63. Using the Hosmer Lemeshow test, a C statistic of 8.066 (p
= 0.472) was obtained, indicating satisfactory model fit. The calculated
area under the receiver operating characteristic curve was 0.706 (p =
0.0002), indicating good discriminatory power. Emergency intraoperative
conversion to ONCAB occurred in 6.53% of patients. The mortality in the
ONCAB group was significantly higher compared with patients who underwent
successful OPCAB surgery (15.18% v 1.5%, p<0.0001). On multiple regression
analysis with conversion to ONCAB as the endpoint, associated factors were
patients with a higher EuroSCORE II (odds ratio = 1.13, confidence
interval = 1.03-1.27) and more-than-trivial mitral regurgitation (odds
ratio = 1.84, confidence interval = 1.07-3.06). Net reclassification
improvement of 0.714 (p<0.0001) was obtained when on-pump conversion was
added to the EuroSCORE II. Conclusions The EuroSCORE II has satisfactory
calibration and discrimination power to predict mortality after OPCAB
surgery. Intraoperative conversion to ONCAB is a major complication of
OPCAB surgery. A higher EuroSCORE II also predicts higher probability of
conversion to ONCAB.

<5>
Accession Number
2015204496
Authors
Jia L. Dong R. Zhang F. Wang W. Lu H. Luo Y. Xue Q. Yu B.
Institution
(Jia, Dong, Zhang, Lu, Luo, Xue, Yu) Department of Anesthesiology, Ruijin
Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin Er
Road, Shanghai 200025, China
(Wang) Department of Anesthesiology, Zhejiang Provincial People's
Hospital, Hangzhou, China
Title
Propofol Provides More Effective Protection for Circulating Lymphocytes
Than Sevoflurane in Patients Undergoing Off-Pump Coronary Artery Bypass
Graft Surgery.
Source
Journal of Cardiothoracic and Vascular Anesthesia. 29 (5) (pp 1172-1179),
2015. Date of Publication: 01 Oct 2015.
Publisher
W.B. Saunders
Abstract
Objectives To compare the effects of propofol, sevoflurane, and the
combination of the 2 on circulating lymphocytes in patients undergoing
off-pump coronary artery bypass graft (OPCAB) surgery. Design A
prospective, randomized study. Setting A university hospital. Participants
One hundred five patients undergoing elective OPCAB surgery. Interventions
Participants were randomized to receive sevoflurane (group S), propofol
(group P), or coadministration (group C) of sevoflurane- and
propofol-maintained anesthesia. Measurements and Main Results Blood
samples were obtained before, during, and after surgery. Caspase-3 and
apoptosis-inducing factor in lymphocytes were evaluated by Western blot.
During surgery, 5 minutes after revascularization of the left anterior
descending artery, 5 minutes after all anastomoses (T4), and after the
sternal closure (T5), caspase-3 expression of group S was higher than that
of group P (p = 0.02) and group C (p = 0.02). At T4 and T5, expression of
active apoptosis-inducing factor in group S was higher than that in the
other 2 groups (p = 0.03 and p = 0.04, respectively). 24 hours after
surgery, the lymphocyte count of group S (0.55/nL) was lower than that of
group P (0.73/nL, p = 0.02) and group C (0.73/nL, p = 0.03). Intensive
care unit stay of group S (3.0 days) was longer than that of the other 2
groups (2.2 days, p = 0.02 and 2.1 days, p = 0.01). Conclusions OPCAB
surgery was associated with postoperative lymphopenia. Regarding a
protective effect for circulating lymphocytes, propofol and the
combination of sevoflurane- and propofol-maintained anesthesia were both
superior to sevoflurane-maintained anesthesia.

<6>
Accession Number
2015155686
Authors
Kim J.H. Kim H.J. Kim J.Y. Sik Ahn H. Ahn I.M. Choe W.J. Lim C.-H.
Institution
(Kim, Kim, Choe) Department of Anesthesiology and Pain Medicine, Ilsan
Paik Hospital, Inje University, 170 JuHwaRo, IlsanSeoGu, Goyang,
GyungGiDo, South Korea
(Kim, Sik Ahn, Ahn) Department of Preventive Medicine, College of
Medicine, Korea University, Seoul, South Korea
(Ahn) Department of Literary Arts, Brown University, Providence, RI,
United States
(Lim) Department of Anesthesiology and Pain Medicine, Korea University
Medical Center, Seoul, South Korea
Title
Meta-Analysis of Sodium Bicarbonate Therapy for Prevention of Cardiac
Surgery-Associated Acute Kidney Injury.
Source
Journal of Cardiothoracic and Vascular Anesthesia. 29 (5) (pp 1248-1256),
2015. Date of Publication: 01 Oct 2015.
Publisher
W.B. Saunders
Abstract
Objective The aim of this study was to determine whether or not
perioperative administration of sodium bicarbonate had a preventive effect
on cardiac surgery-associated acute kidney injury (CSA-AKI) as shown in
randomized controlled trials. Design The authors conducted a systematic
review and meta-analysis using MEDLINE, EMBASE, the Cochrane Central
Register of Controlled Trials (CENTRAL), and KoreaMed. Setting The authors
searched MEDLINE, EMBASE, CENTRAL, and KoreaMed without language and date
restrictions. They used both MeSH and free-text terms to identify relevant
studies. Electronic searches were undertaken on July 31, 2014.
Participants Five randomized controlled studies included in this review.
Measurements and Main Results There were no differences in the development
of CSA-AKI among patients in the sodium bicarbonate group compared with
those in the control group (5 trials, 1,092 patients; n = 233 of 547 in
sodium bicarbonate (SB) group versus 225 of 545 in control group (SC);
risk ratio (RR), 0.95; 95% confidence interval (CI), 0.74-1.22. Also,
there were no statistical differences in in-hospital mortality (3 trials,
573 patients; n = 21 of 288 in SB versus 14 of 285 in SC; RR, 1.44; 95%
CI, 0.76-2.72), need for renal replacement therapy (4 trials, 1,000
patients; n = 21 of 503 in SB versus 23 of 497 in SC; RR, 0.90; 95% CI,
0.50-1.60), length of stay in the intensive care unit (ICU) (hours) (4
trials, n = 969 patients, weighted men difference (WMD), 2.17; 95% CI,
-1.15-5.49), and length of ventilation (hours) (4 trials, 969 patients;
WMD, 0.34; 95% CI,-0.80-1.48). Conclusions Perioperative administration of
sodium bicarbonate did not reduce the rate of CSA-AKI in randomized
controlled trials. Therefore, use of perioperative administration of
sodium bicarbonate for the prevention of CSA-AKI is questionable.

<7>
Accession Number
2015153297
Authors
Matata B.M. Scawn N. Morgan M. Shirley S. Kemp I. Richards S. Lane S.
Wilson K. Stables R. Jackson M. Haycox A. Mediratta N.
Institution
(Matata, Scawn, Morgan, Shirley, Kemp, Wilson, Stables, Jackson,
Mediratta) Liverpool Heart and Chest Hospital, NHS Foundation Trust,
Thomas Drive, Liverpool L14 3PE, United Kingdom
(Richards, Haycox) School of Management, United Kingdom
(Lane) Department of Biostatistics, University of Liverpool, Liverpool,
United Kingdom
Title
A Single-Center Randomized Trial of Intraoperative Zero-Balanced
Ultrafiltration during Cardiopulmonary Bypass for Patients with Impaired
Kidney Function Undergoing Cardiac Surgery.
Source
Journal of Cardiothoracic and Vascular Anesthesia. 29 (5) (pp 1236-1247),
2015. Date of Publication: 01 Oct 2015.
Publisher
W.B. Saunders
Abstract
Objectives The authors investigated whether zero-balance ultrafiltration
(Z-BUF) during bypass significantly improves clinical and cost outcomes or
biomarkers of kidney injury for patients with preoperative kidney
impairment (estimated glomerular filtration rate [eGFR]<60 mL/minute)
undergoing cardiac surgery. Design A single-center randomized controlled
trial recruited, patients between 2010 and 2013, with a 12-months
follow-up. Setting Hospital. Participants One hundred ninety-nine patients
undergoing cardiac surgery with cardiopulmonary bypass (CPB).
Interventions Patients were assigned randomly to receive zero-balance
ultrafiltration (Z-BUF) or not, with stratification for degree of kidney
dysfunction and diabetes. Measurements and Main Results The authors
assessed clinical efficacy and kidney function biomarkers. Cumulative
probability of discharge from the intensive care unit (ICU) was assessed
by Kaplan-Meier plots and was found not to be significantly different
between the two trial arms (p = 0.61). After adjusting for EuroSCORE,
diabetes, eGFR, cardioplegia types and type of surgery in a Cox
proportional hazard model, hazard ratios (HR) for ICU length of stay
between the Z-BUF and no-Z-BUF groups was not significantly different: HR
(95% CI): 0.89 (0.66, 1.20; p = 0.44). In contrast, significant reductions
in postoperative chest infections and the composite of clinical endpoints
(death, strokes, and myocardial infarctions) in the Z-BUF group were
observed. In addition, Z-BUF significantly abrogated the rise in the
kidney damage markers urinary NGAL/creatinine ratio, urea, creatinine and
eGFR during CPB and adverse events risks. Conclusions Z-BUF during bypass
surgery is associated with significant reductions in morbidity and
biomarkers of CPB-induced acute kidney injury soon after CPB, which are
indicative of clearance of inflammatory/immune mediators from the
circulation.

<8>
Accession Number
2015054774
Authors
Brusen R.M. Hahn R. Cabreriza S.E. Cheng B. Wang D.Y. Truong W. Spotnitz
H.M.
Institution
(Brusen, Hahn, Wang, Spotnitz) Department of Medicine, Columbia
University, New York, NY, United States
(Cabreriza, Truong, Spotnitz) Department of Surgery, Columbia University
Medical Center, Vanderbilt Clinic, 622 West 168th Street, New York, NY
10032, United States
(Cheng) Department of Biostatistics, Columbia University, New York, NY,
United States
Title
Wall Thickness, Pulmonary Hypertension, and Diastolic Filling
Abnormalities Predict Response to Postoperative Biventricular Pacing.
Source
Journal of Cardiothoracic and Vascular Anesthesia. 29 (5) (pp 1155-1161),
2015. Date of Publication: 01 Oct 2015.
Publisher
W.B. Saunders
Abstract
Objective Post-cardiopulmonary bypass biventricular pacing improves
hemodynamics but without clearly defined predictors of response. Based on
preclinical studies and prior observations, it was suspected that
diastolic dysfunction or pulmonary hypertension is predictive of
hemodynamic benefit. Design Randomized controlled study of temporary
biventricular pacing after cardiopulmonary bypass. Setting Single-center
study at university-affiliated tertiary care hospital. Interventions
Patients who underwent bypass with preoperative ejection fraction<40% and
QRS duration>100 ms or double-valve surgery were enrolled. At 3 time
points between separation from bypass and postoperative day 1, pacing
delays were varied to optimize hemodynamics. Participants Data from 43
patients were analyzed. Measurements and Main Results Cardiac output and
arterial pressure were measured under no pacing, atrial pacing, and
biventricular pacing. Preoperative echocardiograms and pulmonary artery
catheterizations were reviewed, and measures of both systolic and
diastolic function were compared to hemodynamic response. Early after
separation, improvement in cardiac output was positively correlated with
pulmonary vascular resistance (R<sup>2</sup> = 0.97, p<0.001), ventricle
wall thickness (R<sup>2</sup> = 0.72, p = 0.002)), and E/e', a measure of
abnormal diastolic ventricular filling velocity (R<sup>2</sup> = 0.56, p =
0.04). Similar trends were seen with mean arterial pressure. QRS duration
and ejection fraction did not correlate significantly with improvements in
hemodynamics. Conclusions There may be an effect of biventricular pacing
related to amelioration of abnormal diastolic filling patterns rather than
electrical resynchronization in the postoperative state.

<9>
Accession Number
2015028228
Authors
Chang J.-E. Min S.-W. Kim C.-S. Lee J.-M. No H. Hwang J.-Y.
Institution
(Chang, Min, Kim, Lee, Hwang) Department of Anesthesiology and Pain
Medicine, SMG-SNU Boramae Medical Center, Boramae-ro, Dongjak-gu, Seoul
156-707, South Korea
(No) Department of Anesthesiology and Pain Medicine, Seoul National
University Hospital, Seoul, South Korea
Title
Effect of Jaw Thrust on Transesophageal Echocardiography Probe Insertion
and Concomitant Oropharyngeal Injury.
Source
Journal of Cardiothoracic and Vascular Anesthesia. 29 (5) (pp 1266-1271),
2015. Date of Publication: 01 Oct 2015.
Publisher
W.B. Saunders
Abstract
Objective The aim of this study was to evaluate the effect of jaw thrust
on transesophageal echocardiography probe insertion and concomitant
oropharyngeal injury. Design A prospective, randomized study Setting
Medical center governed by a university hospital Participants Forty-two
adult patients undergoing cardiovascular surgery were included.
Interventions After the induction of anesthesia, a transesophageal
echocardiography probe was inserted using an anterior jaw lift technique
(conventional group, n = 21) or a jaw thrust-assisted technique (jaw
thrust group, n = 21). Measurements and Main Results The incidence of
oropharyngeal injury, number of insertion attempts, blood on the probe
tip, and presence of persistent oropharyngeal bleeding were evaluated. In
the conventional group, oropharyngeal injury occurred more frequently than
in the jaw-thrust group (52.4% v 9.5%, respectively; p = 0.006). Regarding
transesophageal echocardiography probe insertion, the conventional group
required more attempts than the jaw-thrust group (p = 0.043). The
incidence of blood on the probe tip was higher in the conventional group
than in the jaw-thrust group (p = 0.020), but the presence of persistent
oropharyngeal bleeding was similar between the 2 groups. Conclusions The
jaw-thrust maneuver facilitated the insertion of the transesophageal
echocardiography probe and reduced concomitant oropharyngeal injury.

<10>
Accession Number
2015389408
Authors
Pislaru S.V. Abel M.D. Schaff H.V. Pellikka P.A.
Title
Aortic Stenosis and Noncardiac Surgery: Managing the Risk.
Source
Current Problems in Cardiology. 40 (11) (pp 483-503), 2015. Date of
Publication: November 2015.
Publisher
Mosby Inc.
Abstract
Managing the risk of noncardiac surgery in patients with aortic stenosis
is a problem that is frequently confronted in clinical practice.
Traditionally, patients with severe aortic stenosis were considered to be
at substantial risk during noncardiac surgery, and as such, elective
procedures were avoided before intervention on the aortic valve in most
patients other than those who were ineligible or refused aortic valve
replacement. Recent data suggest that with contemporary anesthesia and
surgical techniques, the risk of noncardiac surgery is substantially lower
than previously believed. We review the existent literature in the field,
and propose a practical approach to complex patients.

<11>
Accession Number
2015875110
Authors
Dall C.H. Gustafsson F. Christensen S.B. Dela F. Langberg H. Prescott E.
Institution
(Dall, Prescott) Department of Cardiology, Bispebjerg Hospital, University
of Copenhagen, Bispebjerg Bakke 23, Copenhagen 2400, Denmark
(Dall) Institute of Sports Medicine Copenhagen ISMC, MRRU, Denmark
(Gustafsson) Department of Cardiology, Heart Centre, Rigshospitalet,
University of Copenhagen, Belgium
(Christensen) Department of Cardiology, Gentofte Hospital, University of
Copenhagen, Australia
(Dela) Xlab, Center for Healthy Aging, University of Copenhagen, Australia
(Langberg) CopenRehab, Department of Public Health, University of
Copenhagen, Copenhagen, Denmark
Title
Effect of moderate- versus high-intensity exercise on vascular function,
biomarkers and quality of life in heart transplant recipients: A
randomized, crossover trial.
Source
Journal of Heart and Lung Transplantation. 34 (8) (pp 1033-1041), 2015.
Article Number: 5978. Date of Publication: August 2015.
Publisher
Elsevier USA
Abstract
Background Growing evidence in long-term treatment of heart transplant
(HTx) recipients indicates effects of high-intensity interval training
(HIIT) on several parameters, including oxygen uptake, vascular function
and psychological distress. In this study we compare the effect of HIIT vs
continued moderate training (CON) on vascular function, biomarkers and
health-related quality of life (HRQoL) in HTx recipients. Methods A
randomized, controlled crossover trial of stable HTx recipients >12 months
after transplantation was done on patients with 12 weeks of HIIT or 12
weeks of CON, followed by a 5-month washout and crossover. Outcomes
included endothelial function, arterial stiffness, biomarkers, HRQoL and
markers of anxiety and depression. Results Sixteen HTx recipients (mean
age 52 years, 75% male) completed the study. HIIT increased
VO<sub>2peak</sub> more than CON (between-group difference, p < 0.001).
The physical component score of the 36-item Short Form (SF-36) was
increased significantly in HIIT patients (p = 0.02) and borderline
increased in CON patients (p = 0.07), whereas there was no significant
effect of exercise on the mental component. Depression score decreased
significantly in HIIT patients (p = 0.04) with no change in CON patients
(p = 0.75), whereas anxiety score decreased significantly in both HIIT (p
< 0.01) and CON (p < 0.05) patients. There were no between-group
differences in any of the measures (all p > 0.05). Arterial stiffness and
biomarkers were not changed, nor did endothelial function change after
HIIT (p = 0.08) or CON (p = 0.68). Conclusions HIIT and CON are both well
tolerated and induce similar improvements in physical components of HRQoL
and in markers of anxiety. Effects of either training modality on vascular
function and biomarkers could not be confirmed.

<12>
Accession Number
2015434312
Authors
Ryan L. Rajah C. Simmers D. Potgieter D. Rodseth R.N.
Institution
(Ryan, Rajah, Rodseth) Perioperative Research Group, Department of
Anaesthetics, Grey's Hospital, Nelson R. Mandela School of Medicine,,
University of KwaZulu-Natal, Pietermaritzburg, South Africa
(Simmers, Potgieter) Department of Anaesthetics, Nelson R. Mandela School
of Medicine, University of KwaZulu-Natal, Durban, South Africa
(Rodseth) Department of Outcomes Research, Cleveland Clinic, Cleveland,
OH, United States
Title
Preoperative B-type natriuretic peptides in patients undergoing noncardiac
surgery: A cumulative meta-analysis.
Source
Southern African Journal of Anaesthesia and Analgesia. 21 (4) (pp 12-22),
2015. Date of Publication: 2015.
Publisher
Medpharm Publications (PO Box 14804, Lyttelton, Gauteng 0157, South
Africa)
Abstract
Background: A plethora of studies have shown elevated preoperative
natriuretic peptide measurements to predict postoperative mortality and
adverse cardiac events. Objectives: The current study aimed to demonstrate
this overwhelming association and to show that further studies of this
nature are unwarranted. Methods: A cumulative meta-analysis of 28 studies
was conducted where the primary outcomes of mortality and adverse cardiac
events were associated with elevated preoperative natriuretic peptides.
Results: Cumulative meta-analysis demonstrated an odds ratio trending to a
constant of 5.66, with a marked narrowing in the 95% confidence interval.
Conclusions: Further studies aiming only to demonstrate an association
between a preoperative natriuretic peptide threshold and the risk of
postoperative adverse cardiac events are not justified. Future
investigation should focus on the clinical implications of these data and
the application of these findings with regard to further investigation,
optimisation and appropriate adaptation of perioperative management.

<13>
Accession Number
2015433504
Authors
Khand A. Patel B. Palmer N. Jones J. Andron M. Perry R. Mehrotra S.
Mitsudo K.
Institution
(Khand, Jones) Department of Cardiology, University Hospital Aintree NHS
Foundation Trust, Liverpool, United Kingdom
(Khand, Patel, Palmer, Andron, Perry) Department of Cardiology, Liverpool
Heart and Chest Hospital, Liverpool, United Kingdom
(Khand) School of Ageing and Chronic Diseases, University of Liverpool,
Liverpool, United Kingdom
(Mehrotra) Department of Cardiology, Narayana Hrudayalaya, Bangalore,
India
(Mitsudo) Department of Cardiology, Kurashiki Central Hospital, Okayama,
Japan
Title
Retrograde wiring of collateral channels of the heart in chronic total
occlusions: A systematic review and meta-analysis of safety, feasibility,
and incremental value in achieving revascularization.
Source
Angiology. 66 (10) (pp 925-932), 2015. Date of Publication: 01 Nov 2015.
Publisher
SAGE Publications Inc.
Abstract
Aim: To conduct a systematic review and meta-analysis on retrograde wiring
in chronic total occlusions (CTOs) with focus on its safety and
feasibility. Methods and Results: We searched publications from 1990 to
December 2013 in PubMed, Ovid, EMBASE, and the Cochrane database inserting
a number of terms relating to the collateral circulation of the heart in
CTOs. A total of 18 case series (n range17-462) with a total of 2280 CTO
revascularization attempts fulfilled criteria for a study of retrograde
wiring of collateral channels in CTOs. There were no randomized studies
comparing a primary antegrade with a primary retrograde approach.
Procedural CTO revascularization rates ranged from 67% to 90.6% with a
large proportion having previously failed an "antegrade" approach. The
septal perforator collaterals and epicardial channels were used in 73.2%
(n = 1670) and 21.7% (n = 495) of cases. Although collateral/coronary
perforation was not infrequent (n = 90, 5%), serious acute complications
were uncommon; in the combined population 18 cases of cardiac tamponade
(0.8%) and 3 deaths (0.1%). Septal perforating wiring (79.3%) was
significantly more likely to be successful compared to epicardial coronary
artery wiring (72.5%) when chosen by the operator as a route of retrograde
access to the CTO body (relative risk 1.11 [95% confidence interval:
1.02-1.20; P =.013]). Conclusion: Successful retrograde wiring of
collateral channels in selected patients undertaken by "CTO dedicated"
operators can significantly enhance the chances of revascularization of
complex CTOs with a low risk of acute serious complications. Septal
perforator channels are significantly more likely to be successfully
retrogradely wired compared to epicardial vessels when either is selected,
by reference to their anatomical suitability by the operator, as a route
of access.

<14>
Accession Number
2015433047
Authors
Hausenloy D.J. Candilio L. Evans R. Ariti C. Jenkins D.P. Kolvekar S.
Knight R. Kunst G. Laing C. Nicholas J. Pepper J. Robertson S. Xenou M.
Clayton T. Yellon D.M.
Institution
(Hausenloy, Candilio, Xenou, Yellon) Hatter Cardiovascular Institute,
University College London, 67 Chenies Mews, London WC1E 6HX, United
Kingdom
(Hausenloy, Yellon) National Institute of Health Research, University
College London Hospitals, Biomedical Research Centre, India
(Evans, Knight, Nicholas, Robertson, Clayton) Clinical Trials Unit, London
School of Hygiene and Tropical Medicine, United Kingdom
(Ariti) Nuffield Trust, United Kingdom
(Kolvekar) Heart Hospital, University College London Hospital, United
Kingdom
(Kunst) King's College London and King's College Hospital, United Kingdom
(Laing) Royal Free Hospital, United Kingdom
(Pepper) National Institute of Health Research Cardiovascular Biomedical
Research Unit, Royal Brompton and Harefield NHS Trust, London, United
Kingdom
(Jenkins) Papworth Hospital, Cambridge, United Kingdom
(Hausenloy) National Heart Research Institute Singapore, National Heart
Centre Singapore, Singapore
(Hausenloy) Cardiovascular and Metabolic Disorders Program, Duke-National
University of Singapore, Singapore
Title
Remote ischemic preconditioning and outcomes of cardiac surgery.
Source
New England Journal of Medicine. 373 (15) (pp 1408-1417), 2015. Date of
Publication: 08 Oct 2015.
Publisher
Massachussetts Medical Society
Abstract
BACKGROUND Whether remote ischemic preconditioning (transient ischemia and
reperfusion of the arm) can improve clinical outcomes in patients
undergoing coronary-artery bypass graft (CABG) surgery is not known. We
investigated this question in a randomized trial. METHODS We conducted a
multicenter, sham-controlled trial involving adults at increased surgical
risk who were undergoing on-pump CABG (with or without valve surgery) with
blood cardioplegia. After anesthesia induction and before surgical
incision, patients were randomly assigned to remote ischemic
preconditioning (four 5-minute inflations and deflations of a standard
blood-pressure cuff on the upper arm) or sham conditioning (control
group). Anesthetic management and perioperative care were not
standardized. The combined primary end point was death from cardiovascular
causes, nonfatal myocardial infarction, coronary revascularization, or
stroke, assessed 12 months after randomization. RESULTS We enrolled a
total of 1612 patients (811 in the control group and 801 in the ischemic-
preconditioning group) at 30 cardiac surgery centers in the United
Kingdom. There was no significant difference in the cumulative incidence
of the primary end point at 12 months between the patients in the remote
ischemic preconditioning group and those in the control group (212
patients [26.5%] and 225 patients [27.7%], respectively; hazard ratio with
ischemic preconditioning, 0.95; 95% confidence interval, 0.79 to 1.15; P =
0.58). Furthermore, there were no significant between- group differences
in either adverse events or the secondary end points of perioperative
myocardial injury (assessed on the basis of the area under the curve for
the high-sensitivity assay of serum troponin T at 72 hours), inotrope
score (calculated from the maximum dose of the individual inotropic agents
administered in the first 3 days after surgery), acute kidney injury,
duration of stay in the intensive care unit and hospital, distance on the
6-minute walk test, and quality of life. CONCLUSIONS Remote ischemic
preconditioning did not improve clinical outcomes in patients undergoing
elective on-pump CABG with or without valve surgery.

<15>
Accession Number
2015433046
Authors
Meybohm P. Bein B. Brosteanu O. Cremer J. Gruenewald M. Stoppe C. Coburn
M. Schaelte G. Boning A. Niemann B. Roesner J. Kletzin F. Strouhal U.
Reyher C. Laufenberg-Feldmann R. Ferner M. Brandes I.F. Bauer M. Stehr
S.N. Kortgen A. Wittmann M. Baumgarten G. Meyer-Treschan T. Kienbaum P.
Heringlake M. Schon J. Sander M. Treskatsch S. Smul T. Wolwender E.
Schilling T. Fuernau G. Hasenclever D. Zacharowski K.
Institution
(Meybohm, Strouhal, Reyher, Zacharowski) Department of Anesthesiology,
Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt,
Theodor-Stern-Kai 7, Frankfurt 60590, Germany
(Meybohm, Bein, Gruenewald) Department of Anesthesiology and Intensive
Care Medicine, United States
(Cremer) Department of Cardiovascular Surgery, University Hospital
Schleswig-Holstein, Campus Kiel, Kiel, Germany
(Brosteanu) Clinical Trial Center, Germany
(Fuernau) Department of Internal Medicine/Cardiology, University of
Leipzig Heart Center, Germany
(Hasenclever) Institute for Medical Informatics, Statistics and
Epidemiology, University of Leipzig, Leipzig, Germany
(Stoppe, Coburn, Schaelte) Department of Anesthesiology, University
Hospital Aachen, Aachen, Germany
(Boning, Niemann) Department of Cardiovascular Surgery, University of
Giessen, Giessen, Germany
(Roesner, Kletzin) Clinic of Anesthesiology and Intensive Care Medicine,
University Hospital Rostock, Rostock, Germany
(Laufenberg-Feldmann, Ferner) Department of Anesthesiology, Medical Center
of Johannes Gutenberg University, Mainz, Germany
(Brandes, Bauer) Department of Anesthesiology and Intensive Care Medicine,
University Hospital Gottingen, Gottingen, Germany
(Stehr, Kortgen) Department of Anesthesiology and Intensive Care Medicine
and Center for Sepsis Control and Care, Jena University Hospital, Jena,
Germany
(Wittmann, Baumgarten) Department of Anesthesiology and Intensive Care
Medicine, University Hospital Bonn, Bonn, Germany
(Meyer-Treschan, Kienbaum) Department of Anesthesiology and Intensive Care
Medicine, University Hospital Dusseldorf, Dusseldorf, Germany
(Heringlake, Schon) Department of Anesthesiology and Intensive Care
Medicine, University of Lubeck, Lubeck, Germany
(Sander, Treskatsch) Department of Anesthesiology and Intensive Care
Medicine, Charite-Universitatsmedizin Berlin, Campus Charite Mitte,
Germany
(Smul, Wolwender) Department of Anesthesiology, University Hospital
Wurzburg, Wurzburg, Germany
(Schilling) Department of Anesthesiology, University Hospital Magdeburg,
Magdeburg, Germany
Title
A multicenter trial of remote ischemic preconditioning for heart surgery.
Source
New England Journal of Medicine. 373 (15) (pp 1397-1407), 2015. Date of
Publication: 08 Oct 2015.
Publisher
Massachussetts Medical Society
Abstract
Remote ischemic preconditioning (RIPC) is reported to reduce biomarkers of
ischemic and reperfusion injury in patients undergoing cardiac surgery,
but uncertainty about clinical outcomes remains. METHODS We conducted a
prospective, double-blind, multicenter, randomized, controlled trial
involving adults who were scheduled for elective cardiac surgery requiring
cardiopulmonary bypass under total anesthesia with intravenous propofol.
The trial compared upper-limb RIPC with a sham intervention. The primary
end point was a composite of death, myocardial infarction, stroke, or
acute renal failure up to the time of hospital discharge. Secondary end
points included the occurrence of any individual component of the primary
end point by day 90. RESULTS A total of 1403 patients underwent
randomization. The full analysis set comprised 1385 patients (692 in the
RIPC group and 693 in the sham-RIPC group). There was no significant
between-group difference in the rate of the composite primary end point
(99 patients [14.3%] in the RIPC group and 101 [14.6%] in the sham-RIPC
group, P = 0.89) or of any of the individual components: death (9 patients
[1.3%] and 4 [0.6%], respectively; P = 0.21), myocardial infarction (47
[6.8%] and 63 [9.1%], P = 0.12), stroke (14 [2.0%] and 15 [2.2%], P =
0.79), and acute renal failure (42 [6.1%] and 35 [5.1%], P = 0.45). The
results were similar in the per-protocol analysis. No treatment effect was
found in any subgroup analysis. No significant differences between the
RIPC group and the sham-RIPC group were seen in the level of troponin
release, the duration of mechanical ventilation, the length of stay in the
intensive care unit or the hospital, new onset of atrial fibrillation, and
the incidence of postoperative delirium. No RIPC-related adverse events
were observed. CONCLUSIONS Upper-limb RIPC performed while patients were
under propofol-induced anesthesia did not show a relevant benefit among
patients undergoing elective cardiac surgery.

<16>
Accession Number
2015430150
Authors
Al Tmimi L. Van de Velde M. Herijgers P. Meyns B. Meyfroidt G. Milisen K.
Fieuws S. Coburn M. Poesen K. Rex S.
Institution
(Al Tmimi, Van de Velde, Rex) University Hospitals of Leuven, Department
of Anesthesiology, KU Leuven - University of Leuven, Herestraat 49, Leuven
B-3000, Belgium
(Van de Velde, Herijgers, Meyns, Rex) KU Leuven - University of Leuven,
Department of Cardiovascular Sciences, Leuven B-3000, Belgium
(Herijgers, Meyns) University Hospitals of Leuven, Department of Cardiac
Surgery, KU Leuven - University of Leuven, Herestraat 49, Leuven B-3000,
Belgium
(Meyfroidt) University Hospitals Leuven, Department of Intensive Care
Medicine, KU Leuven - University of Leuven, Herestraat 49, Leuven B-3000,
Belgium
(Meyfroidt) KU Leuven - University of Leuven, Department of Intensive Care
Medicine and Cellular and Molecular Medicine, Herestraat 49, Leuven
B-3000, Belgium
(Milisen) KU Leuven - University of Leuven, Department of Public Health
and Primary Care, Leuven B-3000, Belgium
(Fieuws) KU Leuven - University of Leuven, I-Biostat, Leuven B-3000,
Belgium
(Coburn) University Hospital of the RWTH Aachen, Department of
Anesthesiology, Aachen, Germany
(Poesen) University Hospitals Leuven, Laboratory Medicine, KU Leuven -
University of Leuven, Herestraat 49, Leuven B-3000, Belgium
(Poesen) KU Leuven - University of Leuven, Department of Neurosciences,
Laboratory for Molecular Neurobiomarker Research, Herestraat 49, Leuven
B-3000, Belgium
Title
Xenon for the prevention of postoperative delirium in cardiac surgery:
Study protocol for a randomized controlled clinical trial.
Source
Trials. 16 (1) , 2015. Article Number: 449. Date of Publication: October
09, 2015.
Publisher
BioMed Central Ltd.
Abstract
Background: Postoperative delirium (POD) is a manifestation of acute
postoperative brain dysfunction that is frequently observed after cardiac
surgery. POD is associated with short-term complications such as an
increase in mortality, morbidity, costs and length of stay, but can also
have long-term sequelae, including persistent cognitive deficits, loss of
independence, and increased mortality for up to 2 years. The noble gas
xenon has been demonstrated in various models of neuronal injury to
exhibit remarkable neuroprotective properties. We therefore hypothesize
that xenon anesthesia reduces the incidence of POD in elderly patients
undergoing cardiac surgery with the use of cardiopulmonary bypass.
Methods/Design: One hundred and ninety patients, older than 65 years, and
scheduled for elective cardiac surgery, will be enrolled in this
prospective, randomized, controlled trial. Patients will be randomized to
receive general anesthesia with either xenon or sevoflurane. Primary
outcome parameter will be the incidence of POD in the first 5
postoperative days. The occurrence of POD will be assessed by trained
research personnel, blinded to study group, with the validated 3-minute
Diagnostic Confusion Assessment Method (3D-CAM) (on the intensive care
unit in its version specifically adapted for the ICU), in addition to
chart review and the results of delirium screening tools that will be
performed by the bedside nurses). Secondary outcome parameters include
duration and severity of POD, and postoperative cognitive function as
assessed with the Mini-Mental State Examination. Discussion: Older
patients undergoing cardiac surgery are at particular risk to develop POD.
Xenon provides remarkable hemodynamic stability and has been suggested in
preclinical studies to exhibit neuroprotective properties. The present
trial will assess whether the promising profile of xenon can be translated
into a better outcome in the geriatric population. Trial registration:
EudraCT Identifier: 2014-005370-11(13 May 2015).

<17>
Accession Number
2015430147
Authors
Crespo-Leiro M.G. Stypmann J. Schulz U. Zuckermann A. Mohacsi P. Bara C.
Ross H. Parameshwar J. Zakliczynski M. Fiocchi R. Hoefer D. Deng M.
Leprince P. Hiller D. Eubank L. Deljkich E. Yee J.P. Vanhaecke J.
Institution
(Crespo-Leiro) Instituto de Investigacion Biomedica de A Coruna (INIBIC),
Complexo Hospitalario Universitario de A Coruna (CHUAC), SERGAS,
Universidade da Coruna (UDC), Coruna, Spain
(Stypmann) University Hospital Muenster, Muenster, Germany
(Schulz) Ruhr University of Bochum, Bad Oeynhausen, Germany
(Zuckermann) Medical University of Vienna, Vienna, Austria
(Mohacsi) University Hospital Bern, Bern, Switzerland
(Bara) Hannover Medical School, Hannover, Germany
(Ross) Toronto General Hospital, Toronto, Canada
(Parameshwar) Papworth Hospital, Papworth Everard, Cambridge, United
Kingdom
(Zakliczynski) Silesian Center for Heart Disease, Zabrze, Poland
(Fiocchi) Ospedali Riuniti di Bergamo, Bergamo, Italy
(Hoefer) Innsbruck Medical University, Innsbruck, Austria
(Deng) David Geffen School of Medicine, University of California, Los
Angeles, United States
(Leprince) Groupe Hospitalier Pitie-Salpetriere, Paris, France
(Hiller, Eubank, Deljkich, Yee) CareDx, Brisbane, United States
(Vanhaecke) University Hospital of Leuven, Leuven, Belgium
(Vanhaecke) Department of Cardiology, Herestraat 49, Leuven 3000, Belgium
Title
Performance of gene-expression profiling test score variability to predict
future clinical events in heart transplant recipients.
Source
BMC Cardiovascular Disorders. 15 (1) , 2015. Article Number: 120. Date of
Publication: October 09, 2015.
Publisher
BioMed Central Ltd.
Abstract
Background: A single non-invasive gene expression profiling (GEP) test
(AlloMap) is often used to discriminate if a heart transplant recipient is
at a low risk of acute cellular rejection at time of testing. In a
randomized trial, use of the test (a GEP score from 0-40) has been shown
to be non-inferior to a routine endomyocardial biopsy for surveillance
after heart transplantation in selected low-risk patients with respect to
clinical outcomes. Recently, it was suggested that the within-patient
variability of consecutive GEP scores may be used to independently predict
future clinical events; however, future studies were recommended. Here we
performed an analysis of an independent patient population to determine
the prognostic utility of within-patient variability of GEP scores in
predicting future clinical events. Methods: We defined the GEP score
variability as the standard deviation of four GEP scores collected >315
days post-transplantation. Of the 737 patients from the Cardiac Allograft
Rejection Gene Expression Observational (CARGO) II trial, 36 were assigned
to the composite event group (death, re-transplantation or graft failure
>315 days post-transplantation and within 3 years of the final GEP test)
and 55 were assigned to the control group (non-event patients). In this
case-controlled study, the performance of GEP score variability to predict
future events was evaluated by the area under the receiver operator
characteristics curve (AUC ROC). The negative predictive values (NPV) and
positive predictive values (PPV) including 95 % confidence intervals (CI)
of GEP score variability were calculated. Results: The estimated
prevalence of events was 17 %. Events occurred at a median of 391
(inter-quartile range 376) days after the final GEP test. The GEP
variability AUC ROC for the prediction of a composite event was 0.72 (95 %
CI 0.6-0.8). The NPV for GEP score variability of 0.6 was 97 % (95 % CI
91.4-100.0); the PPV for GEP score variability of 1.5 was 35.4 % (95 % CI
13.5-75.8). Conclusion: In heart transplant recipients, a GEP score
variability may be used to predict the probability that a composite event
will occur within 3 years after the last GEP score. Trial registration:
Clinicaltrials.gov identifier NCT00761787

<18>
Accession Number
2015363529
Authors
Spoelstra-De Man A.M.E. Smit B. Oudemans-Van Straaten H.M. Smulders Y.M.
Institution
(Spoelstra-De Man, Smit, Oudemans-Van Straaten) Department of Intensive
Care, VU University Medical Centre, Amsterdam, Netherlands
(Smulders) Department of Internal Medicine, VU University Medical Centre,
Amsterdam, Netherlands
Title
Cardiovascular effects of hyperoxia during and after cardiac surgery.
Source
Anaesthesia. 70 (11) (pp 1307-1319), 2015. Date of Publication: November
2015.
Publisher
Blackwell Publishing Ltd
Abstract
During and after cardiac surgery with cardiopulmonary bypass, high
concentrations of oxygen are routinely administered, with the intention of
preventing cellular hypoxia. We systematically reviewed the literature
addressing the effects of arterial hyperoxia. Extensive evidence from
pre-clinical experiments and clinical studies in other patient groups
suggests predominant harm, caused by oxidative stress, vasoconstriction,
perfusion heterogeneity and myocardial injury. Whether these alterations
are temporary and benign, or actually affect clinical outcome, remains to
be demonstrated. In nine clinical cardiac surgical studies in low-risk
patients, higher oxygen targets tended to compromise cardiovascular
function, but did not affect clinical outcome. No data about potential
beneficial effects of hyperoxia, such as reduction of gas micro-emboli or
post-cardiac surgery infections, were reported. Current evidence is
insufficient to specify optimal oxygen targets. Nevertheless, the safety
of supraphysiological oxygen suppletion is unproven. Randomised studies
with a variety of oxygen targets and inclusion of high-risk patients are
needed to identify optimal oxygen targets during and after cardiac
surgery.

<19>
Accession Number
2015094380
Authors
Reardon M.J. Adams D.H. Kleiman N.S. Yakubov S.J. Coselli J.S. Deeb G.M.
Gleason T.G. Lee J.S. Hermiller J.B. Chetcuti S. Heiser J. Merhi W. Zorn
G.L. Tadros P. Robinson N. Petrossian G. Hughes G.C. Harrison J.K. Maini
B. Mumtaz M. Conte J.V. Resar J.R. Aharonian V. Pfeffer T. Oh J.K. Qiao H.
Popma J.J.
Institution
(Reardon, Kleiman) Houston Methodist DeBakey Heart and Vascular Center,
6550 Fannin, Suite 1401, Houston, TX 77030, United States
(Adams) Mount Sinai Health System, New York, NY, United States
(Yakubov) Riverside Methodist Hospital, Columbus, OH, United States
(Coselli) Texas Heart Institute, St. Luke's Medical Center, Houston, TX,
United States
(Deeb, Chetcuti) University of Michigan Medical Center, Ann Arbor, MI,
United States
(Gleason, Lee) University of Pittsburgh Medical Center, Pittsburgh, PA,
United States
(Hermiller) St. Vincent Medical Center, Indianapolis, IN, United States
(Heiser, Merhi) Spectrum Health System, Grand Rapids, MI, United States
(Zorn, Tadros) University of Kansas Hospital, Kansas City, KS, United
States
(Robinson, Petrossian) St. Francis Hospital, Roslyn, NY, United States
(Hughes, Harrison) Duke University Medical Center, Durham, NC, United
States
(Maini, Mumtaz) PinnacleHealth, Wormleysburg, PA, United States
(Conte, Resar) Johns Hopkins Hospital, Baltimore, MD, United States
(Aharonian, Pfeffer) Kaiser Permanente-Los Angeles Medical Center, Los
Angeles, CA, United States
(Oh) Mayo Clinic, Rochester, MN, United States
(Qiao) Medtronic, Inc., Minneapolis, MN, United States
(Popma) Beth Israel Deaconess Medical Center, Boston, MA, United States
Title
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding
Transcatheter Aortic Valve Replacement.
Source
Journal of the American College of Cardiology. 66 (2) (pp 113-121), 2015.
Article Number: 21354. Date of Publication: 14 Jul 2015.
Publisher
Elsevier USA
Abstract
Background The U.S. pivotal trial for the self-expanding valve found that
among patients with severe aortic stenosis at increased risk for surgery,
the 1-year survival rate was 4.9 percentage points higher in patients
treated with a self-expanding transcatheter aortic valve bioprosthesis
than in those treated with a surgical bioprosthesis. Objectives
Longer-term clinical outcomes were examined to confirm if this mortality
benefit is sustained. Methods Patients with severe aortic stenosis who
were at increased surgical risk were recruited. Eligible patients were
randomly assigned in a 1:1 ratio to transcatheter aortic valve replacement
with the self-expanding transcatheter valve (transcatheter aortic valve
replacement [TAVR] group) or to aortic valve replacement with a surgical
bioprosthesis (surgical group). The 2-year clinical and echocardiographic
outcomes were evaluated in these patients. Results A total of 797 patients
underwent randomization at 45 centers in the United States. The rate of
2-year all-cause mortality was significantly lower in the TAVR group
(22.2%) than in the surgical group (28.6%; log-rank test p < 0.05) in the
as-treated cohort, with an absolute reduction in risk of 6.5 percentage
points. Similar results were found in the intention-to-treat cohort
(log-rank test p < 0.05). The rate of 2-year death or major stroke was
significantly lower in the TAVR group (24.2%) than in the surgical group
(32.5%; log-rank test p = 0.01). Conclusions In patients with severe
aortic stenosis who are at increased surgical risk, the higher rate of
survival with a self-expanding TAVR compared with surgery was sustained at
2 years. (Safety and Efficacy Study of the Medtronic CoreValve System in
the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very
High Risk Subjects Who Need Aortic Valve Replacement; NCT01240902).

<20>
Accession Number
2015071348
Authors
Seripa D. Latina P. Fontana A. Gravina C. Lattanzi M. Savino M. Gallo A.P.
Melchionda G. Santini S.A. Margaglione M. Copetti M. di Mauro L. Panza F.
Greco A. Pilotto A.
Institution
(Seripa, Gravina, Panza, Greco, Pilotto) Geriatric Unit and
Gerontology-Geriatrics Research Laboratory, Department of Medical
Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG),
Italy
(Latina, Melchionda) Recovery Unit 1, Emergency Department, IRCCS Casa
Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy
(Fontana, Copetti) Biostatistics Unit, IRCCS Casa Sollievo della
Sofferenza, San Giovanni Rotondo (FG), Italy
(Lattanzi) Medical Systems S.p.A., Genova, Italy
(Savino, Gallo, di Mauro) Laboratory of Clinical Chemistry, Department of
Clinical Pathology, IRCCS Casa Sollievo della Sofferenza, San Giovanni
Rotondo (FG), Italy
(Santini) Laboratory of Hormonal Analyses and Clinical Molecular Biology,
Department of Diagnostics and Laboratory Medicine, Catholic University
School of Medicine, Rome, Italy
(Margaglione) Chair of Medical Genetics, Department of Biomedical
Sciences, University of Foggia, Foggia, Italy
(Panza) Neurodegenerative Disease Unit, Department of Basic Medicine,
Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy
(Panza) Department of Clinical Research in Neurology, University of Bari
Aldo Moro, Pia Fondazione Cardinale G. Panico, Lecce, Italy
(Pilotto) Geriatrics Unit, Azienda ULSS16 Padova, S. Antonio Hospital,
Padova, Italy
Title
Role of CYP2D6 Polymorphisms in the Outcome of Postoperative Pain
Treatment.
Source
Pain Medicine (United States). 16 (10) (pp 2012-2023), 2015. Date of
Publication: October 2015.
Publisher
Blackwell Publishing Inc.
Abstract
Objective: To investigate the role of CYP2D6 phenotype in the outcome of
postoperative (PO) pain (POP) treatment. Design: Longitudinal cohort
study. Open-label trial with post hoc analysis. Setting: General Hospital
Surgery and Recovery Units. Patients: Ninety unrelated Caucasians
submitted to abdominal/thoracic surgery. Interventions: Standard
multimodal POP treatment including opioids (tramadol) and nonsteroidal
anti-inflammatory drugs (ketoprofen) at different dosages and infusion
rates according to the predicted mild, moderate, or severe POP. Outcome
Measures: Pain (Numeric Rating Scale-NRS) and sedation (Ramsay Sedation
Scale-RSS) up to 24 hours after surgery. By genotyping 16 CYP2D6 alleles,
the four CYP2D6 phenotypes poor metabolizer (PM), intermediate
metabolizers (IM), extensive metabolizers (EM) and ultrarapid metabolizers
(UM) were predicted. Results: As compared with the CYP2D6-EM phenotype, in
the early PO time (30 min) a higher RSS mean score in IM was observed
(P=0.035). A suggestion towards higher mean score in PM (P=0.091) and a
minor mean score in UM (P=0.091) was also detected. No difference in the
outcome of pain across the CYP2D6 phenotypes was observed. Conclusions: In
respect to the normal CYP2D6 phenotype, our results suggested that slowly
metabolizers (IMs and PMs) might have a major sedation, whereas more rapid
metabolizers (UM) a minor sedation, in the early time after surgery. A
minor role of CYP2D6 phenotype in PO analgesia may be suggested.

<21>
Accession Number
2015433022
Authors
Heiberg J. Redington A. Hjortdal V.E.
Institution
(Heiberg, Hjortdal) Dept. of Cardiothoracic and Vascular Surgery, Aarhus
University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus N 8200,
Denmark
(Heiberg, Hjortdal) Dept. of Clinical Medicine, Aarhus University
Hospital, Denmark
(Redington) Dept. of Pediatrics, Cincinnati Children's Hospital, United
States
Title
Exercise capacity and cardiac function after surgical closure of
ventricular septal defect - Is there unrecognized long-term morbidity?.
Source
International Journal of Cardiology. 201 (pp 590-594), 2015. Date of
Publication: 10 Oct 2015.
Publisher
Elsevier Ireland Ltd
Abstract
Adult survivors of congenital heart disease form a continuously growing
population, as each successive cohort graduating from pediatric care
expands the total number of patients worldwide. Consequently, there is an
increasing interest and study of their late pathophysiology, the
understanding of which can only truly be understood during very long-term
follow-up. Indeed, we have already learned that, for some patient groups,
hitherto unexpected problems may only develop decades after surgery.
Consequently, many patients require careful follow-up in ACHD clinics
throughout life. However, in the most frequent congenital heart disease,
ventricular septal defect (VSD), most guidelines recommend that
specialized follow-up in ACHD clinics may only be indicated for those
patients with significant residual anatomic problems, or overt pulmonary
hypertension. Indeed, the late outcome for patients undergoing
'uncomplicated' repair in childhood has been described as benign. However,
recent data suggest that such characterization may be premature. Several
studies have described abnormalities of right ventricular structure and
function which, in turn, may be directly related to abnormal functional
capacity when formally tested. Furthermore, the longer-term implications
of e.g. right bundle branch block and chronotropic incompetence continue
to be explored. In this review we will examine these emerging data, and
discuss whether amendments to the international guidelines for these
patients' may be justified.

<22>
Accession Number
2015432631
Authors
Whitlock R.P. Devereaux P.J. Teoh K.H. Lamy A. Vincent J. Pogue J.
Paparella D. Sessler D.I. Karthikeyan G. Villar J.C. Zuo Y. Avezum A.
Quantz M. Tagarakis G.I. Shah P.J. Abbasi S.H. Zheng H. Pettit S.
Chrolavicius S. Yusuf S.
Institution
(Whitlock, Devereaux, Lamy, Vincent, Pogue, Pettit, Chrolavicius, Yusuf)
Population Health Research Institute, Hamilton Health Sciences and
McMaster University, Hamilton, ON L8L 2X2, Canada
(Whitlock, Lamy) Department of Surgery, McMaster University, Hamilton, ON,
Canada
(Whitlock, Devereaux, Lamy) Department of Clinical Epidemiology and
Biostatistics, McMaster University, Hamilton, ON, Canada
(Devereaux, Yusuf) Department of Medicine, McMaster University, Hamilton,
ON, Canada
(Teoh) Department of Surgery, Southlake Regional Health Centre, Newmarket,
ON, Canada
(Paparella) University of Bari Aldo Moro, Bari, Italy
(Sessler) Department of Outcomes Research, Cleveland Clinic, Cleveland,
OH, United States
(Karthikeyan) All India Institute of Medical Sciences, New Delhi, India
(Villar) Fundacion Cardio Infantil, Instituto de Cardiologia, Bogota,
Colombia
(Zuo) Department of Anesthesiology, West China Hospital, Sichuan
University, Chengdu, China
(Avezum) Divisao de Pesquisa, Instituto Dante Pazzanese de Cardiologia,
Sao Paulo, Brazil
(Quantz) London Health Sciences Centre, London, ON, Canada
(Tagarakis) Department of Cardiovascular and Thoracic Surgery, University
of Thessaly, Larissa, Greece
(Shah) Princess Alexandra Hospital, Woolloongabba, Brisbane, QLD,
Australia
(Abbasi) Tehran Heart Centre, Tehran University of Medical Sciences,
Tehran, Iran, Islamic Republic of
(Zheng) First Teaching Hospital, Xinjiang Medical University, Urumqi,
China
Title
Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): A
randomised, double-blind, placebo-controlled trial.
Source
The Lancet. 386 (10000) (pp 1243-1253), 2015. Date of Publication: 26 Sep
2015.
Publisher
Lancet Publishing Group
Abstract
Background Cardiopulmonary bypass initiates a systemic inflammatory
response syndrome that is associated with postoperative morbidity and
mortality. Steroids suppress inflammatory responses and might improve
outcomes in patients at high risk of morbidity and mortality undergoing
cardiopulmonary bypass. We aimed to assess the effects of steroids in
patients at high risk of morbidity and mortality undergoing
cardiopulmonary bypass. Methods The Steroids In caRdiac Surgery (SIRS)
study is a double-blind, randomised, controlled trial. We used a central
computerised phone or interactive web system to randomly assign (1:1)
patients at high risk of morbidity and mortality from 80 hospital or
cardiac surgery centres in 18 countries undergoing cardiac surgery with
the use of cardiopulmonary bypass to receive either methylprednisolone
(250 mg at anaesthetic induction and 250 mg at initiation of
cardiopulmonary bypass) or placebo. Patients were assigned with block
randomisation with random block sizes of 2, 4, or 6 and stratified by
centre. Patients aged 18 years or older were eligible if they had a
European System for Cardiac Operative Risk Evaluation of at least 6.
Patients were excluded if they were taking or expected to receive systemic
steroids in the immediate postoperative period or had a history of
bacterial or fungal infection in the preceding 30 days. Patients,
caregivers, and those assessing outcomes were masked to allocation. The
primary outcomes were 30-day mortality and a composite of death and major
morbidity (ie, myocardial injury, stroke, renal failure, or respiratory
failure) within 30 days, both analysed by intention to treat. Safety
outcomes were also analysed by intention to treat. This study is
registered with ClinicalTrials.gov, number NCT00427388. Findings Patients
were recruited between June 21, 2007, and Dec 19, 2013. Complete 30-day
data was available for all 7507 patients randomly assigned to
methylprednisolone (n=3755) and to placebo (n=3752). Methylprednisolone,
compared with placebo, did not reduce the risk of death at 30 days (154
[4%] vs 177 [5%] patients; relative risk [RR] 087, 95% CI 070-107, p=019)
or the risk of death or major morbidity (909 [24%] vs 885 [24%]; RR 103,
95% CI 095-111, p=052). The most common safety outcomes in the
methylprednisolone and placebo group were infection (465 [12%] vs 493
[13%]), surgical site infection (151 [4%] vs 151 [4%]), and delirium (295
[8%] vs 289 [8%]). Interpretation Methylprednisolone did not have a
significant effect on mortality or major morbidity after cardiac surgery
with cardiopulmonary bypass. The SIRS trial does not support the routine
use of methylprednisolone for patients undergoing cardiopulmonary bypass.
Funding Canadian Institutes of Health Research.

<23>
Accession Number
2015430681
Authors
Al Tmimi L. Van Hemelrijck J. Van De Velde M. Sergeant P. Meyns B. Missant
C. Jochmans I. Poesen K. Coburn M. Rex S.
Institution
(Al Tmimi, Van Hemelrijck, Van De Velde, Missant, Rex) Department of
Anaesthesiology, KU Leuven, University of Leuven, Herestraat 49, Leuven
B-3000, Belgium
(Sergeant, Meyns) Department of Cardiac Surgery, KU Leuven, University of
Leuven, Herestraat 49, Leuven B-3000, Belgium
(Jochmans) Department of Abdominal Transplant Surgery, KU Leuven,
University of Leuven, Herestraat 49, Leuven B-3000, Belgium
(Poesen) Department of Laboratory Medicines, KU Leuven, University of
Leuven, Herestraat 49, Leuven B-3000, Belgium
(Van Hemelrijck, Van De Velde, Sergeant, Meyns, Missant, Rex) Department
of Cardiovascular Sciences, KU Leuven, University of Leuven, Herestraat
49, Leuven B-3000, Belgium
(Jochmans) Department of Microbiology and Immunology, KU Leuven,
University of Leuven, Herestraat 49, Leuven B-3000, Belgium
(Poesen) Department of Neurosciences, KU Leuven, University of Leuven,
Herestraat 49, Leuven B-3000, Belgium
(Coburn) Department of Anaesthesiology, University Hospital of the RWTH
Aachen, Aachen, Germany
Title
Xenon anaesthesia for patients undergoing off-pump coronary artery bypass
graft surgery: A prospective randomized controlled pilot trial.
Source
British Journal of Anaesthesia. 115 (4) (pp 550-559), 2015. Date of
Publication: October 2015.
Publisher
Oxford University Press
Abstract
Background Off-pump coronary artery bypass (OPCAB) surgery carries a high
risk for haemodynamic instability and perioperative organ injury.
Favourable haemodynamic effects and organ-protective properties could
render xenon an attractive anaesthetic for OPCAB surgery. The primary aim
of this study was to assess whether xenon anaesthesia for OPCAB surgery is
non-inferior to sevoflurane anaesthesia with regard to intraoperative
vasopressor requirements. Methods Forty-two patients undergoing elective
OPCAB surgery were enrolled in this prospective, single-blind, randomized
controlled pilot trial. Patients were randomized to either xenon (50-60
vol%) or sevoflurane (1.1-1.4 vol%) anaesthesia. Primary outcome was
intraoperative noradrenaline requirements necessary to achieve predefined
haemodynamic goals. Secondary outcomes included safety variables such as
the occurrence of adverse events (intraoperatively and during a 6-month
follow-up after surgery) and the perioperative cardiorespiratory and
inflammatory profile. Results Baseline and intraoperative data did not
differ between groups. Xenon was non-inferior to sevoflurane, as xenon
patients required significantly less noradrenaline intraoperatively to
achieve the predefined haemodynamic goals {geometric mean 428 [95%
confidence interval (CI) 312, 588] vs 1702 [1267, 2285] mug, P<0.0001}. No
differences were found for safety. Significantly more sevoflurane patients
developed postoperative delirium (POD) (hazard ratio 4.2, P=0.044). The
average arterial pressure was lower in the sevoflurane group {median75
[interquartile range (IQR) 6] vs 72 [4] mmHg, P=0.002}. No differences
were found for other haemodynamic parameters, the respiratory profile and
the perioperative release of inflammatory cytokines, troponin T, serum
protein S-100beta and erythropoietin. Conclusions Compared with
sevoflurane, xenon anaesthesia allows a significant reduction in
vasopressor administration in OPCAB surgery. Moreover, xenon anaesthesia
was associated with a lower risk for POD, a finding that has to be
confirmed in larger studies. Clinical trial registration
ClinicalTrials.gov (NCT01757106) and EudraCT (2012-002316-12).

<24>
Accession Number
2015431844
Authors
Wang M. Zhang G. Wang Y. Zhou K. Liu T. Zhang Y. Guo A. An Y. Zhang X. Li
Y.
Institution
(Wang, Zhang, Wang, Zhou, Liu, Zhang, Guo, An, Zhang, Li) Department of
Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang,
Hebei, China
Title
Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in
treatment of non-ST-elevation myocardial infarction following percutaneous
coronary intervention.
Source
Therapeutics and Clinical Risk Management. 11 (pp 1469-1473), 2015. Date
of Publication: 28 Sep 2015.
Publisher
Dove Medical Press Ltd. (PO Box 300-008, Albany, Auckland, New Zealand)
Abstract
Objective: To study the effect of bivalirudin plus loading dose of
cilostazol-based triple-antiplatelet therapy strategy in patients
undergoing percutaneous coronary intervention (PCI). Methods: One hundred
and fifty-three patients with non-ST-segment elevation myocardial
infarction who underwent PCI were divided into control group and
cilostazol group. Patients in control group were given aspirin and
clopidogrel and those in cilostazol group were given aspirin, clopidogrel,
and cilostazol once 2 hours before PCI and for 30 days after PCI.
Bivalirudin was given to all patients before and during the PCI. Results:
After PCI, the Thrombolysis In Myocardial Infarction myocardial perfusion
grade (TMPG) III in cilostazol group was higher than that in control group
(89.19% versus 72.15%, P, 0.05). At 30 days, the incidence of major
adverse cardiac events was significantly lower in cilostazol group
compared with that in control group (6.76% versus 17.72%, P, 0.05).
However, the rates of cardiac death, nonfatal reinfarction, target vessel
revascularization, new congestive heart failure, and subacute stent
thrombosis did not significantly differ between the two groups. In
addition, the rates of minor or major bleeding or thrombocytopenia did not
significantly differ between the two groups. Conclusion: Bivalirudin plus
loading dose of cilostazol-based triple-antiplatelet therapy strategy in
PCI increased TMPG III, decreased major adverse cardiac events, and did
not increase the incidence of bleeding and thrombocytopenia.

<25>
Accession Number
2015325292
Authors
Xu L. Yu C. Jiang J. Zheng H. Yao S. Pei L. Sun L. Xue F. Huang Y.
Institution
(Xu, Yu, Huang) Department of Anesthesiology, Peking Union Medical College
Hospital, Chinese Academy of Medical Sciences, Peking Union Medical
College, Beijing, China
(Jiang, Xue) Department of Epidemiology and Biostatistics, Institute of
Basic Medical Science, Chinese Academy of Medical Sciences, Beijing, China
(Zheng) Department of Anesthesiology, First Affiliated Hospital of
Xinjiang Medical University, Urumqi, China
(Yao) Department of Anesthesiology, Union Hospital, Tong Ji Medical
College, Huazhong University of Science and Technology, Wuhan, Hubei,
China
(Pei) Department of Anesthesiology, First Affiliated Hospital of China
Medical University Graduate School, Shenyang, Liaoning, China
(Sun) Department of Anesthesiology, Cancer Hospital of Chinese Academy of
Medical Sciences, Beijing, China
Title
Major adverse cardiac events in elderly patients with coronary artery
disease undergoing noncardiac surgery: A multicenter prospective study in
China.
Source
Archives of Gerontology and Geriatrics. 61 (3) (pp 503-509), 2015. Date of
Publication: November 2015.
Publisher
Elsevier Ireland Ltd
Abstract
Background: Major adverse cardiac events (MACEs) are important causes of
perioperative morbidity and mortality for elderly patients undergoing
non-cardiac surgery. Treatment and control rates for coronary artery
disease (CAD) in Chinese patients are poorer than rates in western
countries. However, no previous prospective study has focused on
perioperative MACE in this population. Our aim was to ascertain the
incidence and risk factors associated with MACEs in Chinese patients.
Methods: Consecutive CAD patients, aged >60 years, who underwent
non-cardiac surgery at five medical centers in China, were prospectively
enrolled. Clinical variables, including electrocardiogram and troponin I
levels, were evaluated to estimate MACEs. The main outcome was occurrence
of at least one perioperative MACE from admittance to 30 days after
surgery, defined as any of the following complications: cardiac death,
nonfatal cardiac arrest, acute myocardial infarction (MI), congestive
heart failure (CHF), and angina. MACE independent risk factors were based
on the Andersen-Gill multiplicative intensity model. Results: Of the 1422
patients recruited, 129 (9.1%) developed at least one MACE, and cardiac
death occurred in 11 patients (0.8%). The independent risk factors
contributing to postoperative MACE included age >75 years, female gender,
history of MI, history of hypertension, high-risk surgery, intraoperative
hypotension, and intraoperative hypoxemia. Conclusions: The incidence of
MACE in Chinese elderly patients with CAD who underwent non-cardiac
surgery was 9.1%. Seven independent risk factors for a perioperative MACE
were identified. Preventing intraoperative hypoxemia and hypotension may
reduce the occurrence of MACE in these high risk patients.

<26>
Accession Number
2015428009
Authors
Nosotti M. Rosso L. Tosi D. Palleschi A. Mendogni P. Righi I. Marenghi C.
Santambrogio L.
Institution
(Nosotti, Rosso, Tosi, Palleschi, Mendogni, Righi, Santambrogio) Thoracic
Surgery and Lung Transplant Unit, Fondazione IRCCS Ca Granda Ospedale
Maggiore Policlinico, University of Milan, Milan, Italy
(Marenghi) Department of Anesthesia and Intensive Care, Fondazione IRCCS
Ca Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
Title
Preventive analgesia in thoracic surgery: Controlled, randomized,
double-blinded study.
Source
European Journal of Cardio-thoracic Surgery. 48 (3) (pp 428-434), 2015.
Date of Publication: 2015.
Publisher
European Association for Cardio-Thoracic Surgery
Abstract
OBJECTIVES: Preventive analgesia is defined as a treatment that is
commenced before the surgical procedure in order to diminish the
physiological consequences of afferent nociceptive transmission caused by
the procedure and prevent central sensitization. The analysis of
randomized studies of preventive analgesia is controversial. The aim of
this study was to check the analgesic efficacy of preoperative
administration of dextromethorphan associated with intercostal nerve block
with levobupivacaine in thoracotomy patients who refused or had a
contraindication to epidural analgesia. METHODS: This study was a
four-arm, double-blinded, randomized placebo-controlled trial. Patients
were allocated following close block randomization into four arms: 'Group
A' preoperative dextromethorphan and preoperative intercostal block (IB),
'Group B' preoperative placebo and preoperative IB, 'Group C' preoperative
dextromethorphan and postoperative IB, 'Group D' preoperative placebo and
postoperative block. The primary end-point was the cumulative morphine
consumption (CMC) within the first 14 days after surgery. RESULTS: A total
of 400 patients were enrolled and 395 completed the study. There were no
statistical differences among the groups in terms of demographic and
surgical data; in contrast, preoperative quality-of-life scores were
heterogeneous. The mean CMCs were as follows: Group A 111.4 mg, Group B
121.5 mg, Group C 126.8 mg, Group D 138.3 mg. Group A mean was lower than
the maximum (P = 0.0001). The CMC value did not correlate with age, sex,
body mass index, education, type of surgery, length or width of the
incision and rib fracture. Postoperative functional data and
post-thoracotomy syndrome prevalence were homogeneous; female gender
resulted predictive for post-thoracotomy syndrome. CONCLUSIONS: Results
indicate that preoperative administration of dextromethorphan associated
with preoperative IB with levobupivacaine provided preventive analgesia,
decreasing analgesic administration during the early postoperative period
compared with placebo and/or postoperative IB. This study failed in
detecting any effect of preventive analgesia on functional items and
post-thoracotomy syndrome.

<27>
Accession Number
2015428001
Authors
Gaudino M. Leone A. Lupascu A. Toesca A. Mazza A. Ponziani F.R. Flore R.
Tondi P. Massetti M.
Institution
(Gaudino, Leone, Mazza, Massetti) Department of Cardiovascular Science,
Catholic University, Rome, Italy
(Lupascu, Ponziani, Flore, Tondi) Department of Angiology, Catholic
University, Rome, Italy
(Toesca) Department of Human Anatomy, Catholic University, Rome, Italy
Title
Morphological and functional consequences of transradial coronary
angiography on the radial artery: Implications for its use as a bypass
conduit.
Source
European Journal of Cardio-thoracic Surgery. 48 (3) (pp 370-374), 2015.
Date of Publication: 2015.
Publisher
European Association for Cardio-Thoracic Surgery
Abstract
OBJECTIVES: To assess the degree of damage to the radial artery (RA) in
coronary artery bypass grafting (CABG) patients who underwent preoperative
transradial coronary angiography (RA-CA). METHODS: From May 2012 to
October 2013, 50 consecutive CABG patients who underwent RA-CA were
prospectively enrolled in the study. All patients underwent echo-Doppler
evaluation of the RA of the catheterized arm; the contralateral RA was
used as control. The distal segment of the RA was submitted to
immunohistochemical assessment of endothelial integrity. Patients were
divided in three groups according to the time interval from angiography to
evaluation: <24 h, >24 h to <7 days and >7 days. RESULTS: Baseline RA
median diameters were 0.25 +/- 0.04 cm in the cannulated arm and 0.22 +/-
0.04 cm in the non-cannulated arm (P = 0.01). The flow-mediated dilatation
(FMD) in the RA in the catheterized arm and in the control arm were 11.6
+/- 7.9 and 14.2 +/- 8.9 (P = 0.01), respectively. A statistically
significant correlation was found between FMD of the catheterized RA and
the time from RA-CA (Pearson's r = 0.348). Linear regression analysis
confirmed that the FMD of the catheterized RA was dependent on days
elapsed from the procedure (P = 0.032; OR 1.11, CI 0.009-0.203).
Immunohistochemical evaluation showed extensive endothelial lesion in all
examined RAs, with a trend towards reduction of the damage with time.
Endothelial function and integrity of the cannulated arm did not reach
those of the control arm in any of the study patients. CONCLUSIONS: RA-CA
produces extensive damage to the RA. The lesions tend to heal with time
but incomplete recovery of endothelial integrity and function is still
present more than 30 days after the procedure. After RA-CA, the cannulated
RA should not be used for CABG.

<28>
Accession Number
2015427999
Authors
Senanayake E.L. Howell N.J. Ranasinghe A.M. Drury N.E. Freemantle N.
Frenneaux M. Oelofse T. Green D. Wilson I.C. Rooney S.J. Mascaro J. Graham
T.R. Bhudia S. Lewis M. Pagano D.
Institution
(Senanayake, Howell, Ranasinghe, Drury, Wilson, Rooney, Mascaro, Graham,
Pagano) Department of Cardiothoracic Surgery, University Hospitals
Birmingham NHS FT, Birmingham, United Kingdom
(Senanayake, Howell, Ranasinghe) School of Clinical and Experimental
Medicine, University of Birmingham, Birmingham, United Kingdom
(Freemantle) Department of Primary Care and Population Health, University
College London, London, United Kingdom
(Frenneaux) School of Medicine, University of Aberdeen, Aberdeen, United
Kingdom
(Oelofse, Green) Department of Cardiothoracic Anaesthesia, Queen Elizabeth
Hospital Birmingham, Birmingham, United Kingdom
(Bhudia) Department of Cardiothoracic Surgery, University Hospital
Coventry and Warwickshire, Coventry, United Kingdom
(Lewis) Department of Cardiothoracic Surgery, Royal Sussex County
Hospital, Brighton, United Kingdom
Title
Multicentre double-blind randomized controlled trial of perhexiline as a
metabolic modulator to augment myocardial protection in patients with left
ventricular hypertrophy undergoing cardiac surgery.
Source
European Journal of Cardio-thoracic Surgery. 48 (3) (pp 354-362), 2015.
Date of Publication: 2015.
Publisher
European Association for Cardio-Thoracic Surgery
Abstract
OBJECTIVES: Patients undergoing cardiac surgery require adequate
myocardial protection. Manipulating myocardial metabolism may improve the
extent of myocardial protection. Perhexiline has been shown to be an
effective anti-anginal agent due to its metabolic modulation properties by
inhibiting the uptake of free fatty acids into the mitochondrion, and
thereby promoting a more efficient carbohydrate- driven myocardial
metabolism. Metabolic modulation may augment myocardial protection,
particularly in patients with left ventricular hypertrophy (LVH) known to
have a deranged metabolic state and are at risk of poor postoperative
outcomes. This study aimed to evaluate the role of perhexiline as an
adjunct in myocardial protection in patients with LVH secondary to aortic
stenosis (AS), undergoing an aortic valve replacement (AVR). METHODS: In a
multicentre double-blind randomized controlled trial of patients with AS
undergoing AVR +/- coronary artery bypass graft surgery, patients were
randomized to preoperative oral therapy with either perhexiline or
placebo. The primary end point was incidence of inotrope use to improve
haemodynamic performance due to a low cardiac output state during the
first 6 h of reperfusion, judged by a blinded end points committee.
Secondary outcome measures included haemodynamic measurements,
electrocardiographic and biochemical markers of new myocardial injury and
clinical safety outcome measures. RESULTS: The trial was halted early on
the advice of the Data Safety and Monitoring Board. Sixty-two patients
were randomized to perhexiline and 65 to placebo. Of these, 112 (54
perhexiline and 48 placebo) patients received the intervention, remained
in the trial at the time of the operation and were analysed. Of 110
patients who achieved the primary end point, 30 patients (16 perhexiline
and 14 placebo) had inotropes started appropriately; there was no
difference in the incidence of inotrope usage OR of 1.65 [confidence
interval (CI): 0.67- 4.06] P = 0.28. There was no difference in myocardial
injury as evidenced by electrocardiogram odds ratio (OR) of 0.36 (CI:
0.07-1.97) P = 0.24 or postoperative troponin release. Gross secondary
outcome measures were comparable between the groups. CONCLUSIONS:
Perhexiline as a metabolic modulator to enhance standard myocardial
protection does not provide an additional benefit in haemodynamic
performance or attenuate myocardial injury in the hypertrophied heart
secondary to AS. The role of perhexiline in cardiac surgery is limited.

<29>
Accession Number
2015427998
Authors
Saurav A. Alla V.M. Kaushik M. Hunter C.C. Mooss A.V.
Institution
(Saurav, Alla, Kaushik, Hunter, Mooss) Division of Cardiology, Creighton
University Medical Center, Omaha, NE, United States
Title
Outcomes of mitral valve repair compared with replacement in patients
undergoing concomitant aortic valve surgery: A meta-analysis of
observational studies.
Source
European Journal of Cardio-thoracic Surgery. 48 (3) (pp 347-353), 2015.
Date of Publication: 2015.
Publisher
European Association for Cardio-Thoracic Surgery
Abstract
Long-term superiority of mitral valve (MV) repair compared with
replacement is well established in degenerative MV disease. In rheumatic
heart disease, its advantages are unclear and it is often performed in
conjunction with aortic valve (AV) replacement. Herein, we performed a
systematic review and meta-analysis comparing outcomes of MV repair vs
replacement in patients undergoing concomitant AV replacement. PubMed,
Cochrane and Web of Science databases were searched up to 25 January 2014
for English language studies comparing outcomes of MV repair vs
replacement in patients undergoing simultaneous AV replacement. Data of
selected studies were extracted. Study quality, publication bias and
heterogeneity were assessed. Analysis was performed using a random effects
model (meta-analysis of observational studies in epidemiology
recommendation). A total of 1202 abstracts/titles were screened. Of these,
20 were selected for full text review and 8 studies (3924 patients) were
included in the final analysis: 1255 underwent MV repair and 2669
underwent replacement. Late outcome data were available in seven studies
(cumulative follow-up: 15 654 patient-years). The early (in hospital and
up to 30 days post-surgery) mortality [risk ratio (RR): 0.68, 95%
confidence interval (CI): 0.53-0.87, P = 0.003] and late (>30 days
post-surgery) mortality (RR: 0.76, 95% CI: 0.64-0.90 P = 0.001) were
significantly lower in the MV repair group compared with the MV
replacement group. The MV reoperation rate (RR: 1.89, 95% CI: 0.87-4.10, P
= 0.108), thromboembolism (including valve thrombosis) (RR: 0.65, 95% CI:
0.38-1.13, P = 0.128) and major bleeding rates (RR: 0.88, 95% CI:
0.49-1.57, P = 0.659) were found to be comparable between the two groups.
In a separate analysis of studies with exclusively rheumatic patients (n =
1106), the early as well as late mortality benefit of MV repair was lost
(RR: 0.92, 95% CI: 0.44-1.90, P = 0.81 and RR: 0.69, 95% CI: 0.39-1.22, P
= 0.199, respectively), whereas the MV reoperation rate became
significantly higher (RR: 5.10, 95% CI: 1.62- 16.05, P = 0.005) with MV
repair. In patients undergoing concomitant mitral and AV surgery, MV
repair is associated with improved early and late survival without any
increased risk for mitral valve reoperation. However, in patients with
rheumatic heart disease MV repair does not impart any survival advantage
while the risk forMV reoperation remains significantly higher.

<30>
Accession Number
72036862
Authors
Binaghi G. Boi A. Congia D. Deidda M. Lilliu M. Loi B. Melis M. Pani A.
Serra E. Porcu M.
Institution
(Binaghi, Boi, Congia, Loi, Melis, Pani, Serra, Porcu) G. Brotzu Hospital,
Department of Cardiology, Cagliari, Italy
(Deidda, Lilliu) University of Cagliari, Cagliari, Italy
Title
Intra-aortic balloon pump counterpulsation in acute coronary syndromes
complicated by cardiogenic shock: What has changed after the IABP-SHOCK II
trial.
Source
European Heart Journal: Acute Cardiovascular Care. Conference: Acute
Cardiovascular Care 2014 Geneva Switzerland. Conference Start: 20141018
Conference End: 20141020. Conference Publication: (var.pagings). 3 (2
SUPPL. 1) (pp 116), 2014. Date of Publication: October 2014.
Publisher
SAGE Publications Inc.
Abstract
Cardiogenic shock (CS) complicates about 4-12% of acute coronary syndromes
(ACS) and is characterized by a high mortality, regardless of its
treatment. In the past, intraaortic balloon counterpulsation (IABP) has
been widely used in CS. However, its efficacy has been questioned by
recent meta-analysis and, in particular by the results of the IABP-SHOCK
II trial. Aim: To evaluate if the clinical use of IABP in CS in a tertiary
referral center was influenced by the more recent data of literature.
Methods: We evaluated retrospectively the use of IABP in patients who were
intended to undergo a primary PCI (pPCI) for ACS fifteen months before
(preS) and fifteen months after (postS) the presentation of the IABP-SHOCK
II trial (ESC Congress 2012, Munich). The analyzed period started on June
2011 and finished in December 2013. The whole month of September 2012 was
intended as a blanking period and was excluded from this analysis. The use
of IABP was decided by the cardiological team on the basis of the clinical
profile of each patient. Results: A total of 554 accesses for pPCI were
performed in the study period, 259 in preS and 295 in postS. In the whole
population, 23 pts (4,1%) underwent IABP, 12 (4,6%) in the preS and 11
(3,7%) in the postS group, p:0.67; of them, 21 (91%) were males (11 of
preS and 10 of postS, p:0.39). The mean age was 61,4+/-10,4 years
(59,6+/-10,2 in preS and 63,4+/-10,7 in postS, p:0.39). In only 13 pts
(56%) the time elapsed between the onset of symptoms and the PCI (TIT) was
<3 hours and no significant difference were found between preS and postS
groups (p:0.68). A left main and/ or 3-vessel coronary artery disease was
detected in all pts of preS, while in postS in 73% (n:8) of the cases
(p:0.09). Total in-hospital mortality was 43% (n:10), of which, 3 pts in
preS (25%) and 7 in postS (64%) [p:0.10]. In the whole population 3 pts
died in cath lab, all belonging to postS. Two pts for each analyzed period
underwent urgent cardiac surgery. Conclusions: Our data, albeit limited
and related to a monocentric series, confirm that utilization of IABP in
ACS is rare and show a non significant difference in the use of that in
the two analyzed periods. Moreover, the data suggest that, in the postS
period, our centre used IABP likely in pts even more critical; in fact,
they had more than twice the mortality, despite is not a significant
difference, maybe due to the small population size, and regardless of TIT
was similar between two groups and the coronary disease had a tendency to
be more complex in preS. Further and larger studies will likely confirm
whether or not these data.